Form 10-Q UNITED GUARDIAN INC For: Mar 31

May 13, 2016 9:03 AM

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2016

TRANSITION REPORT PURSUANT TO 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________ to _________

Commission File Number: 1-10526

UNITED-GUARDIAN, INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware		11-1719724
(State or Other Jurisdiction of		(I.R.S. Employer Identification No.)
Incorporation or Organization)

	230 Marcus Boulevard, Hauppauge, New York 11788
	(Address of Principal Executive Offices)

	(631) 273-0900
	(Registrant’s Telephone Number)

	N/A
	(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Cover Page 1 of 2

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer		☐
Non-accelerated filer		☐ (Do not check if a smaller reporting company)
Accelerated filer		☐
Smaller reporting company		☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.)

Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date:

4,594,319 shares of common stock, par value $.10 per share

(as of May 1, 2016)

Cover Page 2 of 2

UNITED-GUARDIAN, INC.

INDEX TO FINANCIAL STATEMENTS

Page No.

Part I. FINANCIAL INFORMATION

Item 1 - Condensed Financial Statements:

Statements of Income - Three months ended March 31, 2016 and 2015	2

Statements of Comprehensive Income - Three months ended March 31, 2016 and 2015	3

Balance Sheets – March 31, 2016 and December 31, 2015	4-5

Statements of Cash Flows – Three months ended March 31, 2016 and 2015	6

Notes to Condensed Financial Statements	7-10

Item 2 - Management's Discussion and Analysis of Financial Condition and Results of Operations	10-15

Item 3 - Quantitative and Qualitative Disclosures About Market Risk	15

Item 4 - Controls and Procedures	15-16

Part II. OTHER INFORMATION

Item 1 - Legal Proceedings	16

Item 1A - Risk Factors	16

Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds	16

Item 3 - Defaults Upon Senior Securities	16

Item 4 - Mine Safety Disclosures	16

Item 5 - Other Information	16

Item 6 - Exhibits	16

Signatures	17

Page 1 of 17

Part I. FINANCIAL INFORMATION

ITEM 1. Condensed Financial Statements.

UNITED-GUARDIAN, INC.

STATEMENTS OF INCOME

(UNAUDITED)

	THREE MONTHS ENDED MARCH 31,
	2016		2015

Net sales	$	2,262,576	$	4,372,393

Costs and expenses:
Cost of sales		897,725		1,679,202
Operating expenses		467,556		460,927
Research and development		177,566		166,308
Total costs and expenses		1,542,847		2,306,437

Income from operations		719,729		2,065,956

Other income:
Investment income		43,312		53,454

Income before provision for income taxes		763,041		2,119,410

Provision for income taxes		237,950		658,900

Net income	$	525,091	$	1,460,510

Earnings per common share (Basic and Diluted)	$	0.11	$	0.32

Weighted average shares – basic and diluted		4,594,319		4,596,439

See notes to condensed financial statements

Page 2 of 17

UNITED-GUARDIAN, INC.

STATEMENTS OF COMPREHENSIVE INCOME

(UNAUDITED)

	THREE MONTHS ENDED MARCH 31,
	2016		2015

Net income	$	525,091	$	1,460,510

Other comprehensive income:

Unrealized gain on marketable securities during period		151,068		98,870

Income tax expense related to other comprehensive income		51,363		33,616

Other comprehensive income, net of tax		99,705		65,254

Comprehensive income	$	624,796	$	1,525,764

See notes to condensed financial statements

Page 3 of 17

UNITED-GUARDIAN, INC.

BALANCE SHEETS

ASSETS	MARCH 31, 2016		DECEMBER 31, 2015
	(UNAUDITED)		(AUDITED)
Current assets:
Cash and cash equivalents	$	1,261,308	$	1,080,489
Marketable securities		11,417,153		10,719,470
Accounts receivable, net of allowance for doubtful accounts of $8,654 at March 31, 2016 and December 31, 2015		1,295,747		934,754
Inventories (net)		1,528,456		1,293,642
Prepaid expenses and other current assets		203,766		160,533
Prepaid income taxes		-		95,767
Deferred income taxes		233,305		233,305
Total current assets		15,939,735		14,517,960


Property, plant and equipment:
Land		69,000		69,000
Factory equipment and fixtures		4,181,810		4,175,940
Building and improvements		2,776,602		2,776,602
Total property, plant and equipment		7,027,412		7,021,542
Less: Accumulated depreciation		5,964,759		5,925,429
Total property, plant and equipment, net		1,062,653		1,096,113

Other assets (net):		70,413		74,118
TOTAL ASSETS	$	17,072,801	$	15,688,191

See notes to condensed financial statements

Page 4 of 17

UNITED-GUARDIAN, INC.

BALANCE SHEETS (continued)

LIABILITIES AND STOCKHOLDERS’ EQUITY

	MARCH 31, 2016		DECEMBER 31, 2015
Current liabilities:	(UNAUDITED)		(AUDITED)
Accounts payable	$	348,223	$	96,815
Accrued expenses		1,100,783		785,623
Income taxes payable		141,883		---
Dividends payable		105,929		105,929
Total current liabilities		1,696,818		988,367

Deferred income taxes		169,373		118,010

Commitments and contingencies

Stockholders’ equity:
Common stock $.10 par value, authorized, 10,000,000 shares; 4,594,319 shares issued and outstanding at March 31, 2016 and December 31, 2015		459,432		459,432
Accumulated other comprehensive income		172,066		72,361
Retained earnings		14,575,112		14,050,021
Total stockholders’ equity		15,206,610		14,581,814

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	17,072,801	$	15,688,191

See notes to condensed financial statements

Page 5 of 17

UNITED-GUARDIAN, INC.

STATEMENTS OF CASH FLOWS
(UNAUDITED)

	THREE MONTHS ENDED MARCH 31,
	2016			2015
Cash flows from operating activities:
Net income	$	525,091		$	1,460,510
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		43,036			42,708
Realized loss on sale of investments		10,180			---
Recovery of bad debts		---			(12,326	)
(Decrease) increase in cash resulting from changes in operating assets and liabilities:
Accounts receivable		(360,993	)		(672,432	)
Inventories		(234,814	)		244,953
Prepaid expenses and other assets		(43,233	)		2,260
Prepaid income taxes		95,767			6,449
Accounts payable		251,407			67,150
Income taxes payable		141,883			----
Accrued expenses		315,160			670,676

Net cash provided by operating activities		743,484			1,809,948

Cash flows from investing activities:
Acquisition of property, plant and equipment		(5,870	)		(2,143	)
Proceeds from sale of marketable securities		49,045			---
Purchase of marketable securities		(605,840	)		(2,853,695	)
Net cash used in investing activities		(562,665	)		(2,855,838	)

Net increase (decrease) in cash and cash equivalents		180,819			(1,045,890	)
Cash and cash equivalents at beginning of period		1,080,489			2,023,383
Cash and cash equivalents at end of period	$	1,261,308		$	977,493


Supplemental disclosure of cash flow information
Taxes paid	$	450		$	300

See notes to condensed financial statements

Page 6 of 17

UNITED-GUARDIAN, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

1.	Nature of Business

United-Guardian, Inc. (the “Company”) is a Delaware corporation that, through its Guardian Laboratories division, conducts research, product development, manufacturing and marketing of cosmetic ingredients, personal and health care products, pharmaceuticals, medical products, and proprietary specialty industrial products.

Basis of Presentation

Interim financial statements of the Company are prepared in accordance with Generally Accepted Accounting Principles in the United States of America (“GAAP”) for interim financial information, pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. In the opinion of management, all adjustments, consisting solely of normal recurring accruals, considered necessary for the fair presentation of financial statements for the interim periods have been included. The results of operations for the current period are not necessarily indicative of results that ultimately may be achieved for any other interim period or for the year ending December 31, 2016. The interim unaudited financial statements and notes thereto should be read in conjunction with the audited financial statements and notes thereto contained in our Annual Report on Form 10-K for the year ended December 31, 2015.

3.	Reclassification of Prior Presentation

Certain prior amounts have been reclassified for consistency with the current period presentation. This reclassification had no effect on the reported income from operations. During the third quarter 2015, the Company concluded that it was appropriate to reclassify research and development costs as a separate item on the statements of income. Previously, such expenses were included with operating expenses.

Investments

The fair values of the Company’s marketable securities are determined in accordance with GAAP, with fair value being defined as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the Company utilizes the three-tier value hierarchy, as prescribed by GAAP, which prioritizes the inputs used in measuring fair value, as follows:

Level 1 – inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2 – inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial statement.

Page 7 of 17

Level 3 – inputs to the valuation methodology are unobservable and significant to the fair value measurement.

The following available-for-sale securities, which comprise all the Company’s marketable securities, are re-measured to fair value on a recurring basis and are valued using Level 1 inputs, which are quoted prices (unadjusted) for identical assets in active markets.

March 31, 2016 (Unaudited)
Available for sale:	Cost		Fair Value		Unrealized Gain (Loss)
Fixed income mutual funds	$	10,497,924	$	10,564,616	$	66,692
Equity and other mutual funds		658,523		852,537		194,014
	$	11,156,447	$	11,417,153	$	260,706
December 31, 2015 (Audited)

Available for sale:
Fixed income mutual funds	$	9,968,948	$	9,900,587	$	(68,361	)
Equity and other mutual funds		640,884		818,883		177,999
	$	10,609,832	$	10,719,470	$	109,638

For the first quarter of 2016 there was $10,180 of net realized losses from the sale and redemption of marketable securities.

Investment income consisted principally of unrealized and realized gains and losses, interest income from bonds, mutual funds, and money market funds.

Marketable securities include investments in fixed income and equity mutual funds and government securities, which are classified as “available-for-sale” securities and are reported at their fair values. Unrealized gains and losses on “available-for-sale” securities are reported as accumulated other comprehensive income (loss) in stockholders’ equity, net of the related tax effects. Investment income is recognized when earned. Realized gains and losses on sales of investments are determined on a specific identification basis.

5	Inventories

	March 31, 2016		December 31, 2015
	(Unaudited)		(Audited)
Inventories consist of the following:
Raw materials	$	307,312	$	334,320
Work in process		66,895		44,836
Finished products		1,154,249		914,486
	$	1,528,456	$	1,293,642

Page 8 of 17

Inventories are valued at the lower of cost or current market value. Cost is determined using the average cost method, which approximates cost determined by the first-in, first-out (“FIFO”) method. Finished products inventories at March 31, 2016 and December 31, 2015 are stated net of a reserve of $20,000, for each period, for slow moving and obsolete inventory.

6.	Income Taxes

The Company’s tax provision is based on its estimated annual effective tax rate. The Company continues to fully recognize its tax benefits, which are offset by a valuation allowance to the extent that it is more likely than not that the deferred tax assets will not be realized. As of December 31, 2015 and March 31, 2016, the Company did not have any unrecognized tax benefits.

7.	Comprehensive Income

Accumulated other comprehensive income comprises unrealized gains and losses on marketable securities net of the related tax effect.

Changes in Accumulated Other Comprehensive Income	March 31, 2016			December 31, 2015
Beginning balance	$	72,361		$	259,869
Unrealized gain (loss) on marketable securities before reclassifications - net of tax		110,515			(189,903	)
Realized (loss) gain on sale of securities reclassified from accumulated other comprehensive income		(10,810	)		2,395
Ending balance - net of tax	$	172,066		$	72,361

8.	Defined Contribution Plan

The Company sponsors a 401(k) defined contribution plan (“DC Plan”) that provides for a dollar-for-dollar employer matching contribution of the first 4% of each employee’s pay that is deferred by the employee. Employees become fully vested in employer matching contributions after one year of employment. In addition, the Company has been accruing $175,000 per year toward the payment of a discretionary 401(k) contribution that is apportioned among all employees using a “pay-to-pay” safe harbor formula in accordance with IRS regulations. The Company accrued $43,750 in contributions to the DC Plan for each of the first quarters of 2016 and 2015. For the first quarters of 2016 and 2015 the Company did not make any discretionary contributions to the DC Plan.

Page 9 of 17

9.	Other Information

Accrued Expenses
	March 31, 2016		December 31, 2015

Bonuses	$	375,000	$	250,000
Distribution fees		207,600		206,977
Payroll and related expenses		203,191		109,451
Annual report expenses		40,940		66,000
Audit fee		68,000		82,000
Insurance		124,709		---
Other		81,343		71,195
Total Accrued Expenses	$	1,100,783	$	785,623

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

FORWARD-LOOKING STATEMENTS

Statements made in this Form 10-Q which are not purely historical are forward-looking statements with respect to the goals, plans, objectives, intentions, expectations, financial condition, results of operations, future performance and business of the Company. Forward-looking statements may be identified by the use of such words as "believes," "may," "will," "should," "intends," "plans," "estimates," or "anticipates" or other similar expressions.

Forward-looking statements involve inherent risks and uncertainties, and important factors (many of which are beyond our control) could cause actual results to differ materially from those set forth in the forward-looking statements. In addition to those specific risks and uncertainties set forth in the Company's reports currently on file with the SEC, some other factors that may affect the future results of operations of the Company are: the development of products that may be superior to those of the Company; changes in the quality or composition of the Company's products; lack of market acceptance of the Company's products; the Company's ability to develop new products; general economic or industry conditions; changes in intellectual property rights; changes in interest rates; new legislation or regulatory requirements; conditions of the securities markets; the Company's ability to raise capital; changes in accounting principles, policies or guidelines; financial or political instability; acts of war or terrorism; and other economic, competitive, governmental, regulatory and technical factors that may affect the Company's operations, products, services and prices.

Accordingly, results actually achieved may differ materially from those anticipated as a result of such forward-looking statements, and those statements speak only as of the date they are made.

The Company does not undertake, and specifically disclaims, any obligation to update any forward-looking statements to reflect events or circumstances occurring after the date of such statements.

Page 10 of 17

OVERVIEW

The Company is a Delaware corporation that, through its Guardian Laboratories division, conducts research, product development, manufacturing and marketing of cosmetic ingredients, personal and health care products, pharmaceuticals, medical products, and proprietary specialty industrial products. All of the products that the Company manufactures, with the exception of RENACIDIN^®, are produced at its facility in Hauppauge, New York, and are marketed through marketing partners, distributors, wholesalers, direct advertising, mailings, and trade exhibitions. Its most important product line is its LUBRAJEL^® line of water-based moisturizing and lubricating gels, which are used primarily as ingredients in cosmetic products. The Company’s research and development department is actively working on the development of new products to expand the Company’s line of personal care products. Some of the Company’s products have patent protection, and others are produced using proprietary manufacturing processes.

The Company’s personal care products are marketed worldwide by five marketing partners, of which Ashland Specialty Ingredients (“ASI”) purchases the largest volume of products from the Company. Approximately 65% of the Company’s products are sold, either directly or through the Company’s marketing partners, to end users located outside of the United States.

The Company also sells two pharmaceutical products for urological uses. Those products are sold primarily in the United States through the major drug wholesalers, which in turn sell the products to pharmacies, hospitals, nursing homes and other long-term care facilities, and to government agencies, primarily the United States Department of Veterans Affairs.

The Company’s non-pharmaceutical medical products (referred to hereinafter as “medical products”), such as its catheter lubricants, as well as its specialty industrial products, are sold directly by the Company to the end users or to contract manufacturers utilized by the end users, although they are available for sale on a non-exclusive basis by its marketing partners as well.

While the Company does have competition in the marketplace for some of its products, particularly its cosmetic ingredients, some of its pharmaceutical and medical products have some unique characteristics, and do not have direct competitors. However, these products may have indirect competition from other products that are not marketed as direct competitors to the Company’s products but may have similar functions or properties to the Company’s products.

The Company recognizes revenue when products are shipped, title and risk of loss pass to the customers, persuasive evidence of a sales arrangement exists, and collections are reasonably assured. An allowance for returns, based on historical experience, is taken as a reduction of sales within the same period the revenue is recognized.

Over the years the Company has been issued many patents and trademarks and intends, whenever possible, to make efforts to obtain patents in connection with its product development program. Most of the patents that the Company has been issued have expired; however, the Company does not believe that the expiration of those patents will have any material effect on its sales, since the Company’ most important products rely on trade secrets and proprietary manufacturing methods rather than patent protection.

Page 11 of 17

Critical Accounting Policies

As disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2015, the discussion and analysis of the Company’s financial condition and results of operations are based on its financial statements, which have been prepared in conformity with GAAP. The preparation of those financial statements required the Company to make estimates and assumptions that affect the carrying value of assets, liabilities, revenues and expenses reported in those financial statements. Those estimates and assumptions can be subjective and complex, and consequently actual results could differ from those estimates and assumptions. The Company’s most critical accounting policies relate to revenue recognition, concentration of credit risk, investments, inventory, and income taxes. Since December 31, 2015, there have been no significant changes to the assumptions and estimates related to those critical accounting policies.

The following discussion and analysis covers material changes in the financial condition of the Company since the year ended December 31, 2015, and a comparison of the results of operations for the three months ended March 31, 2016 and March 31, 2015. This discussion and analysis should be read in conjunction with "Management's Discussion and Analysis of Financial Condition and Results of Operations" included in the Company's Annual Report on Form 10-K for the year ended December 31, 2015.

RESULTS OF OPERATIONS

Net Sales

Net sales for the first quarter of 2016 decreased by $2,109,817 (48.3%) as compared with the first quarter of 2015. The change in net sales for the three-month period ended March 31, 2016 was primarily attributable to a decrease in sales of the Company’s personal care products, which was partially offset by increases in sales of its pharmaceutical, medical, and industrial products, as follows:

(a)

Personal care products: Sales of personal care products decreased by $2,375,619 (68.7%) when compared with the same period in 2015. Most of the decrease was attributable to a decline in purchases by ASI of one of the Company’s LUBRAJEL products for sale in China. This decline in purchases by ASI was almost entirely the result of (1) overly optimistic order forecasts by some of ASI’s customers in China, which did not materialize, and (2) a regulatory issue in China that was unrelated to the Company’s LUBRAJEL product but which resulted in a curtailment in the production of some cosmetic products that were formulated with LUBRAJEL. In anticipation of the projected orders for LUBRAJEL by ASI’s customers in China, ASI began building inventory of LUBRAJEL starting in the 4th quarter of 2014. As a result of demand not reaching the original projections, and the temporary restriction imposed by the Chinese government on certain cosmetic products, some of which also contained LUBRAJEL, ASI has been working off its inventory of LUBRAJEL to meet the current demand in China. Based upon ASI’s current order forecasts from its customers in China, ASI’s purchases of LUBRAJEL are expected to resume gradually, but will probably not be significant until at least the 3rd quarter of this year. Going forward, the Company will work closely with ASI to rebuild sales of LUBRAJEL to customers in China. In addition, the Company will assess its pricing strategy, where necessary, in order to be as competitive as possible.

Page 12 of 17

Sales of the Company’s personal care products to the Company’s other five marketing partners decreased by a net $28,395 (7.3%), with an increase to the Company’s second largest marketing partner offset by a decrease to two of its other marketing partners. The sales fluctuations to these five other marketing partners are primarily the result of the timing of customer orders, but sales of the Company’s products in Western Europe continue to be negatively impacted by both the continuing economic problems in Europe, as well as the strong U.S. dollar relative to the Euro, which made the Company’s products less competitive in Europe. There has been more competition in Europe and Asia in the last 2-3 years than there had been in previous years, due to other companies selling imitations of the Company’s products at much lower prices, particularly a Korean company that is manufacturing imitations of the Company’s products in China. This has resulted in a loss of some customers to these competitive products. From time to time it has been necessary for the Company to lower its prices in order to retain or attract certain customers for some of its products, and this has impacted its profit margins on those sales. To date this impact has not been significant, however the Company expects that it will be necessary to continue to lower its prices in certain cases, at least for the near future, in order to remain competitive in the marketplace.

(b)

Pharmaceuticals: Pharmaceutical sales increased by $104,681 (24.3%) in the first quarter of 2016 compared with the same period in 2015. This increase was due primarily to a $90,569 (28.9%) increase in sales of RENACIDIN. Because of two prior RENACIDIN production curtailments by the Company’s previous contract manufacturer, sales of RENACIDIN are still well below historical levels. However, during the past year the Company has seen a gradual increase in RENACIDIN sales. More importantly, in December 2015 the Company received approval by the U.S. Food and Drug Administration to market RENACIDIN in a new easy-to-use single-dose plastic 30mL bottle, which replaces the older 500mL glass bottle. The Company has initiated an aggressive marketing campaign to create awareness of the benefits of the new packaging form among urologists, pharmacists and patients. As a result, the Company anticipates that revenue from the sales of RENACIDIN in this new package form will steadily increase as more urologists and end users become aware of its many benefits. Sales of the new product began on March 31, 2016, at the same time as supplies of the older 500mL bottle were depleted.

(c)

Medical products: Sales of medical products increased by $151,290 (29.1%) for the first quarter of 2016 when compared with the same period in 2015. The Company believes that the increase was primarily due to the timing of orders, as well as the ordering patterns of many of its customers, which order large quantities of product but may not place the same number of orders in every fiscal quarter.

(d)

Industrial and other products: Sales of specialty industrial products, as well as other miscellaneous products, increased by $19,379 (83.5%) for the first quarter of 2016 compared with the same period in 2015.

In addition to the above changes in sales, net sales allowances increased by $9,547 (16.3%) for the first quarter of 2016 when compared with the same period in 2015. This increase was primarily due to increases in chargebacks paid to the U.S. Department of Veterans Affairs, as well as allowances for distribution fees. These increases were offset by decreases in sales discounts and sales returns and allowances.

Page 13 of 17

Cost of Sales

Cost of sales as a percentage of sales increased to 39.7% for the first quarter of 2016, up from 38.4% for the first quarter in 2015. The increase was primarily the result of the change in the Company's product mix of sales. The increase in sales of RENACIDIN, which is manufactured for the Company by a third party manufacturer and has a lower margin than many of the Company’s other products, as well as a decrease in sales of the Company's higher-margin LUBRAJEL products, resulted in the higher cost of sales.

Operating Expenses

Operating expenses, consisting of selling, general, and administrative expenses, increased by $6,629 (1.4%) for the first quarter of 2016 compared with the first quarter of 2015. Operating expenses are expected to remain relatively consistent.

Research and Development Expenses

Research and development expenses increased by $11,258 (6.8%) for the first quarter of 2016 compared with the first quarter of 2015. The increase related to increases in payroll and payroll-related expenses due to normal fluctuations in new product development.

Other Income

Other income decreased by $10,142 (19.0%) for the first quarter of 2016 compared with the first quarter of 2015 due to the Company having realized a loss of $10,180 from the sale of marketable securities in the first quarter of 2016. The Company earns dividend income from both stock and bond mutual funds.

Provision for Income Taxes

The Company's effective income tax rate was approximately 31.0% for the first quarter of 2016 and 2015 and is expected to remain consistent for the current fiscal year.

LIQUIDITY AND CAPITAL RESOURCES

Working capital increased by $713,324 to $14,242,917 at March 31, 2016, up from $13,529,593 at December 31, 2015. The increase in working capital is primarily due to increases in marketable securities and accounts receivable. The current ratio decreased to 9.4 to 1 at March 31, 2016, down from 14.7 to 1 at December 31, 2015. The decrease in the current ratio was primarily due to the effect of an increase in accounts payable and accrued expenses.

The Company believes that its working capital is, and will continue to be, sufficient to support its operating requirements for at least the next twelve months. The Company does not expect to incur any significant capital expenditures for the remainder of 2016.

Page 14 of 17

The Company generated cash from operations of $743,484 and $1,809,948 for the three months ended March 31, 2016 and March 31, 2015, respectively. The decrease was primarily due to the reduction in net income.

Cash used in investing activities for the three-month period ended March 31, 2016 was $562,665, while cash used in investing activities for the three-month period ended March 31, 2015 was $2,855,838. The decrease was primarily due to a decrease in the amount of marketable securities purchased in the first quarter of 2016 compared with the first quarter of 2015.

There was no cash used in financing activities for the first quarters of 2016 and 2015.

The Company expects to continue to use its cash to make dividend payments, purchase marketable securities, and take advantage of other market opportunities that are in the best interests of the Company and its shareholders, should they arise.

OFF BALANCE SHEET-ARRANGEMENTS

The Company has no off balance-sheet transactions that have, or are reasonably likely to have, a current or future effect on the Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

CONTRACTUAL OBLIGATIONS AND COMMITMENTS

The information to be reported under this item is not required of smaller reporting companies.

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

The information to be reported under this item is not required of smaller reporting companies.

Item 4. CONTROLS AND PROCEDURES

(a)

DISCLOSURE CONTROLS AND PROCEDURES

The Company’s management, including its Principal Executive Officer and Principal Financial Officer, has evaluated the design, operation, and effectiveness of the Company’s disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934 (the “Exchange Act”). There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives. Based upon the evaluation performed by the Company’s management, including its Principal Executive Officer and Principal Financial Officer, it was determined that, as of the end of the period covered by this quarterly report, the Company’s disclosure controls and procedures were effective in providing reasonable assurance that information required to be disclosed in the reports filed or submitted pursuant to the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to the Company’s management, including its Principal Executive Officer and Principal Financial Officer, or persons performing similar functions, as appropriate, to allow timely decisions regarding disclosures.

Page 15 of 17

(b)

CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

The Company's Principal Executive Officer and Principal Financial Officer have determined that, during the period covered by this quarterly report, there were no changes in the Company's internal control over financial reporting that materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. They have also concluded that there were no significant changes in the Company’s internal controls after the date of the evaluation.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

None

ITEM 1A. RISK FACTORS

The information to be reported under this item is not required of smaller reporting companies.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None

ITEM 4. MINE SAFETY DISCLOSURES

None

ITEM 5. OTHER INFORMATION

None

ITEM 6. EXHIBITS

31.1	Certification of Kenneth H. Globus, President and Principal Executive Officer of the Company, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2	Certification of Robert S. Rubinger, Chief Financial Officer of the Company, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32	Certifications of Principal Executive Officer and Chief Financial Officer of the Company, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Page 16 of 17

SIGNATURES

In accordance with the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	UNITED-GUARDIAN, INC.
	(Registrant)

	By:	/S/ KENNETH H. GLOBUS
		Kenneth H. Globus
		President


	By:	/S/ ROBERT S. RUBINGER
		Robert S. Rubinger
Date: May 12, 2016		Chief Financial Officer

Page 17 of 17

EXHIBIT 31.1

SECTION 302 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

I, Kenneth H. Globus, certify that:

I have reviewed this Quarterly Report of United-Guardian, Inc. on Form 10-Q for the three-month period ended March 31, 2016;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 12, 2016	By:	/s/ Kenneth H. Globus
		Kenneth H. Globus
		President and Principal Executive Officer

EXHIBIT 31.2

SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER

I, Robert S. Rubinger, certify that:

I have reviewed this Quarterly Report of United-Guardian, Inc. on Form 10-Q for the three-month period ended March 31, 2016;

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 12, 2016	By:	/s/ Robert S. Rubinger
		Robert S. Rubinger
		Chief Financial Officer

EXHIBIT 32

CERTIFICATIONS PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of United-Guardian, Inc. (the "Company") on Form 10-Q for the quarterly period ended March 31, 2016, as filed with the Securities and Exchange Commission (the "Report"), I, Kenneth H. Globus, President and Principal Executive Officer of the Company, and I, Robert S. Rubinger, Chief Financial Officer of the Company, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(i) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(ii) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 12, 2016	By:	/s/ Kenneth H. Globus
		Kenneth H. Globus
		President & Principal Executive Officer

	By:	/s/ Robert S. Rubinger
		Robert S. Rubinger
		Chief Financial Officer

Document And Entity Information - shares	3 Months Ended
Document And Entity Information - shares	Mar. 31, 2016	May. 01, 2016
Entity Registrant Name	UNITED GUARDIAN INC
Entity Central Index Key	0000101295
Trading Symbol	ug
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		4,594,319
Document Type	10-Q
Document Period End Date	Mar. 31, 2016
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q1
Amendment Flag	false

Statements of Income (Unaudited) - USD ($)	3 Months Ended
Statements of Income (Unaudited) - USD ($)	Mar. 31, 2016	Mar. 31, 2015
Net sales	$ 2,262,576	$ 4,372,393
Costs and expenses:
Cost of sales	897,725	1,679,202
Operating expenses	467,556	460,927
Research and development	177,566	166,308
Total costs and expenses	1,542,847	2,306,437
Income from operations	719,729	2,065,956
Other income:
Investment income	43,312	53,454
Income before provision for income taxes	763,041	2,119,410
Provision for income taxes	237,950	658,900
Net income	$ 525,091	$ 1,460,510
Earnings per common share (Basic and Diluted) (in dollars per share)	$ 0.11	$ 0.32
Weighted average shares – basic and diluted (in shares)	4,594,319	4,596,439

Statements of Comprehensive Income (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Net income	$ 525,091	$ 1,460,510
Other comprehensive income:
Unrealized gain on marketable securities during period	151,068	98,870
Income tax expense related to other comprehensive income	51,363	33,616
Other comprehensive income, net of tax	99,705	65,254
Comprehensive income	$ 624,796	$ 1,525,764

Balance Sheets (Current Period Unaudited) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Current assets:
Cash and cash equivalents	$ 1,261,308	$ 1,080,489
Marketable securities	11,417,153	10,719,470
Accounts receivable, net of allowance for doubtful accounts of $8,654 at March 31, 2016 and December 31, 2015	1,295,747	934,754
Inventories (net)	1,528,456	1,293,642
Prepaid expenses and other current assets	$ 203,766	160,533
Prepaid income taxes		95,767
Deferred income taxes	$ 233,305	233,305
Total current assets	15,939,735	14,517,960
Property, plant and equipment:
Land	69,000	69,000
Factory equipment and fixtures	4,181,810	4,175,940
Building and improvements	2,776,602	2,776,602
Total property, plant and equipment	7,027,412	7,021,542
Less: Accumulated depreciation	5,964,759	5,925,429
Total property, plant and equipment, net	1,062,653	1,096,113
Other assets (net):	70,413	74,118
TOTAL ASSETS	17,072,801	15,688,191
Accounts payable	348,223	96,815
Accrued expenses	1,100,783	$ 785,623
Income taxes payable	141,883
Dividends payable	105,929	$ 105,929
Total current liabilities	1,696,818	988,367
Deferred income taxes	$ 169,373	$ 118,010
Commitments and contingencies
Stockholders’ equity:
Common stock $.10 par value, authorized, 10,000,000 shares; 4,594,319 shares issued and outstanding at March 31, 2016 and December 31, 2015	$ 459,432	$ 459,432
Accumulated other comprehensive income	172,066	72,361
Retained earnings	14,575,112	14,050,021
Total stockholders’ equity	15,206,610	14,581,814
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 17,072,801	$ 15,688,191

Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Accounts receivable, allowance	$ 8,654	$ 8,654
Common stock, par value (in dollars per share)	$ 0.10	$ 0.10
Common stock, shares authorized (in shares)	10,000,000	10,000,000
Common stock, shares issued (in shares)	4,594,319	4,594,319
Common stock, shares outstanding (in shares)	4,594,319	4,594,319

Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
Statements of Cash Flows (Unaudited) - USD ($)	Mar. 31, 2016	Mar. 31, 2015
Cash flows from operating activities:
Net income	$ 525,091	$ 1,460,510
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	43,036	$ 42,708
Realized loss on sale of investments	$ 10,180
Recovery of bad debts		$ (12,326)
(Decrease) increase in cash resulting from changes in operating assets and liabilities:
Accounts receivable	$ (360,993)	(672,432)
Inventories	(234,814)	244,953
Prepaid expenses and other assets	(43,233)	2,260
Prepaid income taxes	95,767	6,449
Accounts payable	251,407	$ 67,150
Income taxes payable	141,883
Accrued expenses	315,160	$ 670,676
Net cash provided by operating activities	743,484	1,809,948
Cash flows from investing activities:
Acquisition of property, plant and equipment	(5,870)	$ (2,143)
Proceeds from sale of marketable securities	49,045
Purchase of marketable securities	(605,840)	$ (2,853,695)
Net cash used in investing activities	(562,665)	(2,855,838)
Net increase (decrease) in cash and cash equivalents	180,819	(1,045,890)
Cash and cash equivalents at beginning of period	1,080,489	2,023,383
Cash and cash equivalents at end of period	1,261,308	977,493
Supplemental disclosure of cash flow information
Taxes paid	$ 450	$ 300

Note 1 - Nature of Business

3 Months Ended

Mar. 31, 2016

Notes to Financial Statements

Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]

1.	Nature of Business

Note 2- Basis of Presentation

3 Months Ended

Mar. 31, 2016

Notes to Financial Statements

Basis of Accounting [Text Block]

Basis of Presentation

Note 3 - Reclassification of Prior Presentation

3 Months Ended

Mar. 31, 2016

Notes to Financial Statements

Reclassifications [Text Block]

3.	Reclassification of Prior Presentation

Note 4 - Investments

3 Months Ended

Mar. 31, 2016

Notes to Financial Statements

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]

Investments

Level 1 – inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 3 – inputs to the valuation methodology are unobservable and significant to the fair value measurement.

March 31, 2016 (Unaudited)
Available for sale:	Cost		Fair Value		Unrealized Gain (Loss)
Fixed income mutual funds	$	10,497,924	$	10,564,616	$	66,692
Equity and other mutual funds		658,523		852,537		194,014
	$	11,156,447	$	11,417,153	$	260,706
December 31, 2015 (Audited)

Available for sale:
Fixed income mutual funds	$	9,968,948	$	9,900,587	$	(68,361	)
Equity and other mutual funds		640,884		818,883		177,999
	$	10,609,832	$	10,719,470	$	109,638

For the first quarter of 2016 there was $10,180 of net realized losses from the sale and redemption of marketable securities.

Investment income consisted principally of unrealized and realized gains and losses, interest income from bonds, mutual funds, and money market funds.

Note 5 - Inventories

3 Months Ended

Mar. 31, 2016

Notes to Financial Statements

Inventory Disclosure [Text Block]

5	Inventories

	March 31, 2016		December 31, 2015
	(Unaudited)		(Audited)
Inventories consist of the following:
Raw materials	$	307,312	$	334,320
Work in process		66,895		44,836
Finished products		1,154,249		914,486
	$	1,528,456	$	1,293,642

Note 6 - Income Taxes

3 Months Ended

Mar. 31, 2016

Notes to Financial Statements

Income Tax Disclosure [Text Block]

6.	Income Taxes

Note 7 - Comprehensive Income

3 Months Ended

Mar. 31, 2016

Notes to Financial Statements

Comprehensive Income (Loss) Note [Text Block]

7.	Comprehensive Income

Accumulated other comprehensive income comprises unrealized gains and losses on marketable securities net of the related tax effect.

Changes in Accumulated Other Comprehensive Income	March 31, 2016			December 31, 2015
Beginning balance	$	72,361		$	259,869
Unrealized gain (loss) on marketable securities before reclassifications - net of tax		110,515			(189,903	)
Realized (loss) gain on sale of securities reclassified from accumulated other comprehensive income		(10,810	)		2,395
Ending balance - net of tax	$	172,066		$	72,361

Note 8 - Defined Contribution Plan

3 Months Ended

Mar. 31, 2016

Notes to Financial Statements

Pension and Other Postretirement Benefits Disclosure [Text Block]

8.	Defined Contribution Plan

Note 9 - Other Information

3 Months Ended

Mar. 31, 2016

Notes to Financial Statements

Other Liabilities Disclosure [Text Block]

9.	Other Information

Accrued Expenses
	March 31, 2016		December 31, 2015

Bonuses	$	375,000	$	250,000
Distribution fees		207,600		206,977
Payroll and related expenses		203,191		109,451
Annual report expenses		40,940		66,000
Audit fee		68,000		82,000
Insurance		124,709		---
Other		81,343		71,195
Total Accrued Expenses	$	1,100,783	$	785,623

Note 4 - Investments (Tables)

3 Months Ended

Mar. 31, 2016

Notes Tables

Schedule of Available-for-sale Securities Reconciliation [Table Text Block]

March 31, 2016 (Unaudited)
Available for sale:	Cost		Fair Value		Unrealized Gain (Loss)
Fixed income mutual funds	$	10,497,924	$	10,564,616	$	66,692
Equity and other mutual funds		658,523		852,537		194,014
	$	11,156,447	$	11,417,153	$	260,706
December 31, 2015 (Audited)

Available for sale:
Fixed income mutual funds	$	9,968,948	$	9,900,587	$	(68,361	)
Equity and other mutual funds		640,884		818,883		177,999
	$	10,609,832	$	10,719,470	$	109,638

Note 5 - Inventories (Tables)

3 Months Ended

Mar. 31, 2016

Notes Tables

Schedule of Inventory, Current [Table Text Block]

	March 31, 2016		December 31, 2015
	(Unaudited)		(Audited)
Inventories consist of the following:
Raw materials	$	307,312	$	334,320
Work in process		66,895		44,836
Finished products		1,154,249		914,486
	$	1,528,456	$	1,293,642

Note 7 - Comprehensive Income (Tables)

3 Months Ended

Mar. 31, 2016

Notes Tables

Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]

Changes in Accumulated Other Comprehensive Income	March 31, 2016			December 31, 2015
Beginning balance	$	72,361		$	259,869
Unrealized gain (loss) on marketable securities before reclassifications - net of tax		110,515			(189,903	)
Realized (loss) gain on sale of securities reclassified from accumulated other comprehensive income		(10,810	)		2,395
Ending balance - net of tax	$	172,066		$	72,361

Note 9 - Other Information (Tables)

3 Months Ended

Mar. 31, 2016

Notes Tables

Schedule of Accrued Liabilities [Table Text Block]

Accrued Expenses
	March 31, 2016		December 31, 2015

Bonuses	$	375,000	$	250,000
Distribution fees		207,600		206,977
Payroll and related expenses		203,191		109,451
Annual report expenses		40,940		66,000
Audit fee		68,000		82,000
Insurance		124,709		---
Other		81,343		71,195
Total Accrued Expenses	$	1,100,783	$	785,623

Note 4 - Investments (Details Textual) - USD ($)	3 Months Ended
Note 4 - Investments (Details Textual) - USD ($)	Mar. 31, 2016	Mar. 31, 2015
Marketable Securities, Realized Gain (Loss)	$ (10,180)

Note 4 - Available-for-sale Securities (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2016	Dec. 31, 2015
Fixed Income Securities [Member]
Cost	$ 10,497,924	$ 9,968,948
Fair Value	10,564,616	9,900,587
Unrealized Gain/(Loss)	66,692	(68,361)
Equity And Other Mutual Funds [Member]
Cost	658,523	640,884
Fair Value	852,537	818,883
Unrealized Gain/(Loss)	194,014	177,999
Cost	11,156,447	10,609,832
Fair Value	11,417,153	10,719,470
Unrealized Gain/(Loss)	$ 260,706	$ 109,638

Note 5 - Inventories (Details Textual) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Inventory Valuation Reserves	$ 20,000	$ 20,000

Note 5 - Summary of Inventories (Details) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Raw materials	$ 307,312	$ 334,320
Work in process	66,895	44,836
Finished products	1,154,249	914,486
Total inventories	$ 1,528,456	$ 1,293,642

Note 6 - Income Taxes (Details Textual) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Unrecognized Tax Benefits	$ 0	$ 0

Note 7 - Accumulated Other Comprehensive Income (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2016	Dec. 31, 2015
Beginning balance	$ 72,361	$ 259,869
Unrealized gain (loss) on marketable securities before reclassifications - net of tax	110,515	(189,903)
Realized (loss) gain on sale of securities reclassified from accumulated other comprehensive income	(10,810)	2,395
Ending balance - net of tax	$ 172,066	$ 72,361

Note 8 - Defined Contribution Plan (Details Textual) - DC Plan [Member] - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay	4.00%
Defined Contribution, Discretionary Contribution Plan, Vesting Period	1 year
Defined Contribution Plan, Employer Discretionary Contribution Amount Per Year Authorized	$ 175,000
Defined Contribution Plan, Cost Recognized	43,750	$ 43,750
Defined Contribution Plan, Employer Discretionary Contribution Amount	$ 0	$ 0

Note 9 - Accrued Expenses (Details) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Accrued Annual Report [Member]
Professional fees	$ 40,940	$ 66,000
Accrued Audit Fee [Member]
Professional fees	68,000	82,000
Bonuses	375,000	250,000
Distribution fees	207,600	206,977
Payroll and related expenses	203,191	$ 109,451
Insurance	124,709
Other	81,343	$ 71,195
Accrued expenses	$ 1,100,783	$ 785,623

begin 644 Financial_Report.xlsx
M4$L#!!0    ( #A(K4@L&7F%G0$  ,P2   3    6T-O;G1E;G1?5'EP97-=
M+GAM;,V874_",!2&_PK9K6&E5?$CP(UXJR3Z!^IVQAK:M6G+@']O.]#H,@TH
M2\[-/GA/S_MNIWLNF+SN#+C!5LG*39/2>W-/B,M*4-REVD 5E$);Q7VXM4MB
M>+;B2R!L-!J33%<>*C_TL4ZCK4
M12$RR'6V5F%)ZH,U7 0]&2RX]4]/XJ26\A?O WS[?XVOA;TER/.
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M'C67TD)$.V!+L"S+%4EK0VTPAGEN&;>5ADZ3SX
MB?078VZ:WM*6[13@2=&AXD7U(V8#
M$NTIO8+Z>@"%,;X[)9J4@B,WHX*[O]C\ E!+ P04    "  X2*U(;;-OU%X!
M  !^$0  &@   'AL+U]R96QS+W=OOI1#11>/>HCT74!@:?P__638MS[;
M/\/:15"OS/&YY4TUL^Z7MIAM>A<8\/PZ$K3V_QJ
M2S&<92OCIG/2X_[G[.1\.:3N?*$T>;&NE'!(WSIW]95(\&:\T6S88%B^]_*?
M[;NBJ',Y=?EK(VWXH\)\;9":>!#'@Q@2-(\'S2%!BWC0 A*TC - *
M$K2.!ZTA09MXT 82M(T';2%!E"DR9I@D#6N,UJ1P31BO20&;,&*30C9AS"8%
M;<*H30K;A'&;%+@)(SK.C-&+U9T9M!9VWML(W1FQ6]&:,W
M*WHS1F]6]&:,WJSHS1B]6=&;,7KS1&]?62>7Y^#JMO2/KODV7"V:X.W#_2:/
M3QFGJI_8$ZW#L).8\?IP%,>IGR'FUZ^6XP=02P,$%     @ .$BM2/3'=1&9
M @  J0@  !    !D;V-0&ULO59-<]HP$/TK&I_H@9C0?+0,
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M  !D;V-0U?%UVXU;7?A^_CI-2.BZMAT=O'7C4$*X.36T"EVZ1
M;!$=9RS(+30B3&*%BR0'O]KXFF)(,:FC 8&#Y)&=)]6QVQK:F9*.^*J/C6@1<6J77&M1-
M-Y;]3L7."+X))SFHH3W]_=,#95C25QZ"'JK:MIVT!=7%@7/VNGQXHK-)M0DH
MC(2H"IICYV"1G#N_%+=WJ_NDFF;Y+,VNT[Q897.>Y;R8OQTG^^9O--ST0_Q;
MQV>#M%W46,.%NR6-HN72)X$4!.FU0VW-13C"?!$3+.S?/T#BY:!>2)=M!UUK
MO0H5W:\Q.KZ621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H
M.'GS[BYBZ(:(E/)X8-DOV]:[MR_>X%#BVR]*+41B1%G\@MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVW
MO@C(WXV(]ZMOFCU7H5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?
M-*HU+,76>)7 \:V@S&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='
MU!=*Y \FIS_I,C0'HYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z"
M>P'_T=HWPJOX@L Y?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH
M8U=RSTS0LS
M0[=R2^JVE+ZU)CA*]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^
M VVZG=PZ.)Z8D;D*TU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=
MQXCRHB'NH8:8S\-#AWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1
M O)256 Q6\8#*Y"B?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>K
MRMYEL<%5'<]56_*POFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=
M[=7GFYRN>B)V^I=WP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71%
M B.5' 86%S+D4.Z2D 83  >LX=SFWJXPD6L_UC6
M'ODRWSEPVSK> U[F$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=
MX Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%
MFAHSU8NL.8T*;T'50.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'M
MB[\!4$L#!!0    ( #A(K4A!NF)%-P(  .<(   -    >&POY7!PW9L?I_892@SK!99/@C3'UQR!H\@T5I)FKFDJX
M*946Q,"CKH*FUI04C0T2/%B$X3(0A$F0QJ62TU(LD,;-(]H2#OZ1=<\55QH9Z!5H<(@D@GJ/6\)9IID%2R(8WWEX
M80'7WMY/,*FTR^TS'.>9AV,F764)#OO/\]-E([L[;'F,\VEY *1Q38RA6J[@
M ?7V>E=#<5))ZD4ZOR>\*TUVT>+J(, =D#=3NJ!ZR!SA/93&G)8& C2K-O8T
MJK;2E3%*@%$P4BE)N*7<1_0&T.:4\WL[S-_+"7=7(N]CO^,0(ZMB;T(C>G,<
M ]?4X)#-P1_.PMR*A>N7WXY\+>?WBMRNR^_V?27O2G=O8(O4B7EG_9I:!?<0=[=+)%
M!Q1E+>.&R;T&8O_W[JQN/MEPXP8%SJ(;EZ>[-22#MXY)%B K:$E:;KZQK3+N
M,L&C_<7*CY:#UWJ@2/!H?Z4%:\6U4S"^VJ2_ %!+ P04    "  X2*U(E)HX
MZ50#   >"@  #P   'AL+W=OB<=&&YRY>59[OYX-AUC6T$A\;]=@Z-[*ND9Z&KK;H5VM5 GGMFP;,'Y8
MC$;3H0,MO;(&:[7&;$/#M]!P[4!66 /X1G>P1BJ3'7_ V4II^ D."2SD>GTE
M&YAGCSH36J*_J)2':IZ-:6@?8.>":]>GK=)A,!E-LF& ;9=Z[41I*^A@BUKA
MK\V-3%2PDJWV"PIV^]YYEA?CHIAVC/#83P4/R('A@I"E5_>PD,MY-LJ$;+W]
MJ+0'=RX]?'*V72MS2ZQ,K)1#?Q.6&Y]LE%&-^AWBIA'6]N&S=>JW-5[JF])9
MK>.L<"-.HC?@WRL4HU?ESH->+K^'2LRSZ8B ]PK54FGEG^99_*\AK&3X8BDQ
M_<__A(G)V998G)A*7!A/%'%INN)1:D(,]/!E%5_L9HK^N,LJ[U+%03>>LA!(
M*.R*$*5M0 Q^&-G&DC%0P4#%OT!GMB%Y:C!(J0]8!MIGH/W7H%.II2E!Q)RB
M&)RUSH657H-3MA(,-&:@\?^")@PT8:#)/YR\(<,LP3]V_$!1PEYD\V\XVG+08[\W<$[C$X
MSI_&^5'>A7SLU17-V\Q]V(.B+4-U^#2VUM[FW>(VY?:<2 SBD-^(Z#N+=Y2MP7->H%<7?S
ME+RI7(L!1W%_\Y3 O2F*D7$4-SA_H\)B< Y>*HUBP0]!;G.1LCF@3NYIP.(I+7J0D#S*FKK48O 4-SU(N7Z41>5
M:PEU\4BM$6X7R5'<]N)@\_5^_F!772RAG<'X&NH'RM#CT$]W,HTGP-!V;Y>#G91?&<@VXP6> C
M;AH929#_CD$_F=)HWC^C?U?IBN6?$,-'TORI+[P2JXW#X(*OZ-[P-S+\P&,.
MF0QX)@U3O\'YSCAIGY8P:-&'OM:=N@[ZGPR.-K\!C@8X&6#^I2$9#&'?H 1U.1S .2)T /]XEA3VV 5AQ,138/2!U :MAS&Y!I
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M5"OQO3$-&GSE\G8E]UQW8#W@I']^4$Q?->5_4$L#!!0    ( #A(K4BI\&PO=V]R:W-H965T&ULC9;=CILP$(5?
M!?$ B_^-5TFD#5757E1:]:*]9A,G00LX!6>S??O:0)+!^X/6-OELZK9?I@=KC\]9UF\.NBG[)W/4K?MG9[JFM.ZRVV?]L=/E=@AJ
MZHP@)+*FK-ITM1C67KO5PIQL7;7ZM4OZ4].4W=^UKLUYF>+TLO"SVA^L7\A6
MB^P:MZT:W?:5:9-.[Y;I"WXNL/"20?&KTN<>G"<>_LV8=W_Q?;M,D6?0M=Y8
MGZ)TAP]=Z+KVF5SE/U/26TT?",\OV;\.[3K\M[+7A:E_5UM[<+0H3;9Z5YYJ
M^].0:<*T3
M#Z!3 +T%L*'3D6SHZTMIR]6B,^>D/Y;^;N-G)^]\$IK7ZL
M2+[(/GR>24(&R1I*\%61N>31"B2=AQ-8(5:@F"G4_0KT4F&\?*$@GJ)Y"3%"
MC))V+$$$X5+$= 74,2H)5?0^#[OPR)&'09X'=HP'_7 8'VP9'_OA@#-74A(>
MDQ50AH54!)'[."+ $1"'1G$$W#8A.1=1G+D,*2+OT\B 1D(:%J61L&LIN8C3
MS&1"4)3?I\D#FAS21._!.H=E.",YDU$=1 8^"/-&VUPK4D5A)
M\,9!'"@C2' %[NE_<3 *7@5OI#>@!QK"..@(0_NA>;2E27-Y;2F.OC3%3,8I
MX^P!'A+R0+>BT;U;3YIIC]V3Q7 <".H(QHIA] !2Z'\8&B!#<:29 U*I>%17
MS'2"YPH]0L1"(FB!8?.3)4^:Z6X0CE145\QTV-D&?VB30E/%T%59\(#D$Q+T
M2_2$<4Q5!"KZ@*7BT%,Q-%46-U4\LTNN&,7Q5S44.NL(OZ(9F H:W>V'::E/
M-N;4VO&3?5V]3F0OQ$\5P?K:3VK#M'%+LUH;VH]<[Z4^E;&*>K\<*:XV58O$ZLJW]02P,$%     @ .$BM
M2%K.]C(T @  >08  !@   !X;"]W;W)K[%X[B1-0#69M)W3??GT XB!+Z0W&YO]G
MOC%F*$?*/GF#L?"^.M+SK=\(,6R"@!\;W"'^0@?$SIN_([M1WN>4M[C^'SUM]%FSI7"BWXW>*16_>>8C]0^JDF/T];/U0(F."C4!&0
M'&ZXQH2H0#+QWRGF/:4RVO=S]%==K:0_((YK2OZT)]%(V-#W3OB,KD1\T/$-
M3R4 %?!("==7[WCE@G:SQ?D
MNE)#INOZ@02J2D9'CP](O>QH(^5,!9&1/:ZC,;-=LC(N5V]5FI;!3<69)+&6
M[&U)M"@"&=R9(?8?[;%ECUT)Z@=%\3Q#,F*
M@2L8:,-D3AAH[VV4P,3)8JN2!$;P.4NV8LEL%F?%^\RNN,A"X&2Q55 >A_0Y
M2[YBR6V6PGGFVY=Z!"-AS='Y:XW\#RP3
M@L]"W69J.TUK-!-!A[G1+W^;ZC]02P,$%     @ .$BM2.8BON5,!   EQ, 
M !@   !X;"]W;W)KN^[R%$7MZ[&H\O9+?2G.[I>WNJGRSFTV[U%[:8K\,#2J
MR@B%T%&5G\[;_6[8]ZW9[^J/KCR=BV_-IOVHJKSY+RW*^OJ\A>V\X_OI_=CU
M.Z+]+KJU.YRJXMR>ZO.F*=Z>MU_A*9/81X;$WZ?BVI+OFQ[^I:Y_]!M_'IZW
MHFY]]^'X3K\E[PMLKK\YW3H
MCHY6;#>'XBW_*+OO]?6/8AJ#ZCM\KMY
MTPZ]->-TN9&U;N_G7HE=]-GW,T5PB*0T@EPB\SJ!6R1RQV0R[@ PY#@II-(]#8Z"%DO(QC0UH+*4)END8
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M:H&ZUK"74@K4HF"$02M8"V9^4FEK(5E3EX7&16IANI.XVO+O1+W+=A9WP\W,GMTP4FANIN0UO;O2J7-VO#E83F1=,
MW#2N*6LP%#=ZXN8+&U0^D@Q/[3Q)7@[<%;GB]H:AMI%JVVAN<:1>)C3VO( 6
M,LLD-UG/SV)4UF;-[(9J1:I6PSYFI4B=&;N:0"(_NW=RRT2A7-&3*R][].6*
M8J' ]W(&I5[A51EZ55*O6M[V,JA/C8*%TB%("B5<^;""*I2KI'*UO.VE)U?5
M3]-"X>%67H5TF=:-EEDDK/K^R=<7Z^]Y+\G3$BKU N^7OQ5]Z\
MG\[MYJ7NNKH:7IV\U757N/[$%S?:8Y$?;AME\=;U7TT_#>-[HW&CJR_S:[#;
MN[C]_U!+ P04    "  X2*U(W[.>>>4!  "H!0  &    'AL+W=O?7!JY7J]AC+4PV,R WO
MH-5O*BX84;H49RP[ :0<3(SBT/=3S$C3>GDVK+V)/.,719L6W@22%\:(^/,"
ME/<'+_"FA??F7"NS@/,,WWQEPZ"5#6^[email protected]@/0?[(C6*0?"K@5XZ?!\@P 43LHD$#UGOIE2U
MAO4]5$)%+E2]\_X[C%M(3.")4SG\HM-%*LXFBX<8^;)CTPYC;]^DN]&V; A'
M0W@S!/%#0S0:HID!6[)A7]^((GDF>(]D1\S'#O9:+DR(3D9R2!/V[]([DWKU
MFF^C#%]-SB@)!\F+*PF7%(6K2(*;!.O^BQ#A!&'+Y]"%B.];I!;"2EHK29-%
M4;$J6B6)9B212Y+<-]E:DLAIXF^")4VQIEGEB&<Z59YTAE/ZO)L%WG2_^1YI+,\V#E4
M'3G#3R+.32O1D2M]/H?#5'&N0*?Y&YU:ZVOS5E"HE)D^F7;V)K&%XMUT+]XN
MY_PO4$L#!!0    ( #A(K4@7ED>XU0,   L0   8    >&PO=V]R:W-H965T
M&ULC5?)CN,V$/T50?<9D<6]X3;04A DAP"#.21GM4W;PFAQ
M)+D]^?M0B]TDAX9YL1:_JGI5+#ZQ-M>N_S&OW5FWYI]#US?E:![[8S:<>UWN9Z.FS@ AGC5EU:;;S?SN6[_==)>QKEK]
MK4^&2].4_7^YKKOK:XK3VXOOU?$T3B^R[2:[V^VK1K=#U;5)KP^OZ1M^*4!,
MD!GQ=Z6O@W6?3.3?N^[']/#G_C5%$P==Z]TXN2C-Y4,7NJXG3R;ROZO3SYB3
MH7U_\_[[G*ZA_UX.NNCJ?ZK]>#)L49KL]:&\U./W[OJ'7G-@D\-=5P_S;[*[
M#&/7W$S2I"E_+M>JG:_7Y1^)5K.P :P&<#>XQPD;D-6 ?!K0.=.%V9S7;^58
M;C=]=TV&PI=BGR)8D%TLX0
M!@RI(*RP89ARQ' $'>:EP^QT(@K.O72X;>]5G"WI<(LG)8CP8#8."@22S[D(
MCXNPN9!@:85=,X0E@"#2LF240W@B^P0!Q6P6 Y$+?S
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M&ULC5/;;IPP$/T5RQ\0 [MIJA6+E$U4M0^5HCRTSUX8P(KM
M(;99TK^O+T"6*%+[@F>&<\Z<\:6N>' F*U[4-S>X #:
M_VG1*.Y\:CIF!P.\B20E69%E7YCB0M.JC+4G4Y4X.BDT/!EB1Z6X^7,"B=.1
MYG0I/(NN=Z' JI*MO$8HT%:@)@;:([W/#Z=]0$3 +P&3O8I)\'Y&? G)C^9(
MLV !)-0N*'"_7. !I Q"OO'KK/G>,A"OXT7]6YS6NS]S"P\H?XO&]=YL1DD#
M+1^E>\;I.\PCW ;!&J6-7U*/UJ%:*)0H_I96H>,ZI3]?LYGV.:&8"<4' DN-
MHLU'[GA5&IR('7@XN_S@X2:(>&5BHYI)TWNCUER3N\*@?>P4]N.J$M.:/S)QN/H45TX$UD-[>4
M]/[]K(F$UH7PSL&PO=V]R:W-H965T&ULC5/;;IPP$/T5RQ\0
M<]E-HA6+E$U5)0^5HCRTSUX8P(K-4-LLZ=_'%R!+%:E]P3/#.6?.^%),J-],
M!V#)NY*].=+.VN' F*DZ4-SZ*A.=*'
M]'#:>40 _!0PF:N8>.]GQ#>?/-='FG@+(*&R7H&[Y0*/(*47H;>?,)I34T/!1VE>8>\%*Y0F?$DU&HMJH5"B
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M&ULC5/;;IPP$/T5RQ\0 [O);E:B]Z"+'P4K1P8LF9E"*ZS\GD#@>
M:4KGPJMH6NL+K,C9PJN$@LX([(B&^DCOT\-IZQ$!\%/ :*YBXKV?$=]\\EP=
M:>(M@(32>@7NE@L\@)1>R#7^/6E^M/3$ZWA6?PS3.O=G;N !Y2]1V=:932BI
MH.:#M*\X/L$TPJT7+%&:\"7E8"RJF4*)XN]Q%5U8Q_AGNY]H7Q.RB9 MA'T2
MC,=&P>9W;GF1:QR)Z;D_N_3@[email protected]O9O^F:F[Z+#SS7(T;,:8WY]JD)
MN]I3!;H)5\>0$H?.QBU=JLOMO,_"F7S B[SG#?S@NA&=(6>T[F3#,=2(%IR)
MY.:6DM:]GR614%L?[ERLXY6*B<5^?B#+*RW^ E!+ P04    "  X2*U(9^L1
M_J$!  "Q P  &0   'AL+W=OR>/=" %9LFMAFR?[]^ ($HTNX%=S=5U=5^
MY"/J-],"6/*A9&>.M+6V/S!FRA84-U?80^?^U*@5MR[5#3.]!EX%DI(L2Y(;
MIKCH:)&'VHLN$0"_!(QF%1/O_8SXYI/GZD@3;P$DE-8K<+=&ULC5/;;IPP$/T5RQ\0<]ND6K%(V515\U IRD/[[(4!
MK/A";;.D?U]?@$ 4*7G!,\,Y9\[X4DY*OY@>P*)7P:4YX=[:X4B(J7L0U-RH
M :3[TRHMJ'6I[H@9-- FD 0G69+<$D&9Q%49:D^Z*M5H.9/PI)$9A:#ZWQFX
MFDXXQ4OAF76]]052E63E-4R -$Q)I*$]X?OT>"X\(@!^,YC,)D;>^T6I%Y\\
M-B><> O H;9>@;KE"@_ N1=RC?_.FF\M/7$;+^H_PK3._84:>%#\#VML[\PF
MFTI';9S7]A'F$@Q>L%3?AB^K16"46"D:"OL:5R;!.\4]>S+2/"=E,R%;"
MMR08CXV"S>_4TJK4:D)FH/[LTJ.#:R_BE)$):CI.[XP:5[U6:9:7Y.J%9DRD
MG'>8%4&<^HCOOLW F;_"J'&@'OZCNF#3HHJP[V7 ,K5(6
MG(GDYH!1[][/FG!HK0_O7*SCE8J)5&PO=V]R:W-H965T8UKD_<0/W*/^*RK;.;$))!34?I'W!\3=<1KCV@B5*$[ZD
M'(Q%-5$H4?P]KJ(+ZQC_;";:UX3L0LAFPFT2C,=&P>8#M[S(-8[$]-R?7;IW
M<.U%G#(Q04W'Z9U1XZKG(LUNO8]?3/1
M=]'A9MD]_4'_[22PB0+;U8B[]8@1P)%7);4]TMZYX<"8
MK7M0W-[@ -K_:=$H[GQJ.F8' [R))"59D65W3'&A:57&VI.I2AR=%!J>#+&C
M4MS\.8'$Z4ASNA2>1=>[4&!5R59>(Q1H*U 3 ^V1/N2'TSX@(N"G@,EN8A*\
MGQ%?0O*].=(L6  )M0L*W"\7> 0I@Y!O_'O6?&L9B-MX4?\:I_7NS]S"(\I?
MHG&]-YM1TD#+1^F>.7U*-UJ!8*)8J_IE7HN$[IS_YNIGU,
M*&9"L1(^9=%X:A1M?N&.5Z7!B=B!A[/+#QYN@HA7)C:JF32]-VI]]5+EQ>>2
M78+0C$F4TQ5F13"O_F&+@E[3BPV]^#=]M]#OD\/=MGO^'_WWB\ N">RW KOL
M>L2$.5UCWC=AFSU58+IX=2RI<=0N;>E:76_G0Q'/Y U>E0/OX O]^UD1"ZT)X[V.3KE1*' [+ UE?:?474$L#!!0    (
M #A(K4A;*L#BI0$  +$#   9    >&PO=V]R:W-H965T&,"*S5#;+.G?UQ<@4$5J
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M#Q]&ULC5/;;IPP$/T5RQ\0 [N;K58L
M4C95U#Y4BO+0/GMA "LV0VRSI']?7X! %:E]P3/#.6?.^)*/J%]-"V#)NY*=
M.=/6VO[$F"E;4-S<80^=^U.C5MRZ5#?,]!IX%4A*LBQ)[IGBHJ-%'FK/NLAQ
ML%)T\*R)&93B^O<%)(YGFM*Y\"*:UOH"*W*V\"JAH#,".Z*A/M.']'39>T0 
M_!0PFE5,O/F?4
MN.JM2'>'G-V\T(2)E,L&LR"84_^T14:W]&Q%S_Y-W\WT8W2X6W=/_Z/_?A;8
M18']9L3[[8@1<]EBCG\U8:L]5:";<'4,*7'H;-S2I;K'2QCE&]9YAKV5HH5G34RO%-?_3B!Q.-(-G0HO
MHFZL+[ \8S.O% I:([ E&JHCO=L<3CN/"(!7 8-9Q,1[/R.^^>2I/-+$6P )
MA?4*W"T7N 2;[6W&+EYHQ$3*:869$K8TB!?6OCEL[5^7;>I>%,ON!YUO$:_G!=B]:0,UIWLN$8*D0+SD1R=4U)
MX][/G$BHK _W+M;Q2L7$8C<]D/F5YI]02P,$%     @ .$BM2-" TP6D 0  
ML0,  !D   !X;"]W;W)K&ULA5/;;IPP$/T5RQ\0
ML\ V[8I%RJ:JVH=*41[:9R\,%\7V4-LLZ=_7%R!01I5#F3#MKAQ-CINI U[9S9A)(:&CX*^XS3=YA'.'K!"H4)7U*-QJ)<*)1(
M_AK77H5UBG^.R4Q[GY#.A'0E? X$%AL%FU^YY66A<2)FX/[L#B<'UU[$*1,3
MU'2GF[HZQ?K>*5B8G%8'LCZ
M2LM_4$L#!!0    ( #A(K4@&S,NZI@$  +$#   9    >&PO=V]R:W-H965T
M56R,V?:6MN?&#-E"XJ;.^RA
MZ'#PB 'X+&,TJ)M[[%?'%)S^K
M,TV\!9!06J_ W7*#1Y#2"[G&?R?-MY:>N(YG]>]A6N?^R@T\HOPC*MLZLPDE
M%=1\D/89QQ\PC7#T@B5*$[ZD'(Q%-5,H4?PUKJ(+ZQC_9-E$^YB03H1T(7Q)
M@O'8*-C\QBTO8,7><\;^,5U(SI#KFC=R89CJ!$M
M.!/)W9&2UKV?)9%06Q]F+M;Q2L7$8C\_D.65%O\!4$L#!!0    ( #A(K4A[
M(/0#I@$  +$#   9    >&PO=V]R:W-H965TV/C)FR!<7-#?;0N3\U:L6M2W7#3*^!5X&D),N2
MY!M37'2TR$/M61X\(@-\"1K.*B?=^07SUR<_J1!-O 224UBMPMUSA$:3T0J[Q
MVZ3YT=(3U_&L_A2F=>XOW, CRC^BLJTSFU!20BW1_E[.K%YHPD7+>8!8$<^J?MLCHEIZMZ-G7]-U,
MOXT.=^ONN_NO!?:SP"X*[#\@5]<-Z(SY([email protected]!PH:=W[61()M?7AK8MU
MO%(QL=C/#V1YI<4_4$L#!!0    ( #A(K4@$FSCBO $   ($   9    >&PO
M=V]R:W-H965TQ)G1>V]F.,-LE.I#MP &?7(F] &WQO1[
M0G39 J?Z0?8@[)]:*DZ-=55#=*^ 5I[$&4FBZ(EPV@F<9S[VIO),#H9U MX4
MT@/G5/T] 9/C <=X#KQW36M<@.0967A5QT'H3@JDH#[@8[PO4H?P@%\=C'IE
M(U?[6MO,JDV<];> G54TG-#I+8R?OQU1+:<#6%CWL,&KM@UPN:MW\?125ONQ"&P\1S>3IK.Q'E633&'!.%J"KK9#+_
M<:8?.6W@]'UP_]:5:_!?N!*%K'Z7!WTVM" ,#N+(KY5^EK?OPM6 K>%>5JK[
M#/97I64]A(1!S=_[9]ETSUO_#68N;#D N0 T!HQYE@-B%Q!_!)"NTIZLJ^LK
MUSS/6GD+U(7;;L-[(V^MB7$.5.?6]LME*E-F]BV'.,ZB-VOD-*C3/'J:)47A
MNR2C)C($BQ@H]%.@B0%:3#%58+B>(1XR],.'V$/$ZP;)S"#Q#(@/2?HR>DW3
M:T#"4H:2)6$Q%3)&*$OH.A&>$6&/*/43X9X(>T28) 22)6&!/2( ,$W7B.PNN=IN)W*_0)8 F"P2
M^;HT96Q#PR"<(\$-+7,BEPH:69(L+Y.O! 0P&J,-6&B.A3:TSHD&K 2F_VW(
M Y:G!*E9UA1LP)KOB3#^K(%N3W.B/ADB( 6+>U_AZ2!@))YO:='D:*I%>^J.
M;!7LY;71_&PO=V]R:W-H965T8 _:?VG1*.Y\:@[,]@9X$TE*LB++UDQQ
MH6E5QMJ3J4H\.BDT/!EBCTIQ\W$'$HE4>!:'SH4"JTHV\QJA0%N!FAAH
MM_0VW]1%0$3 BX#!+F(2O.\0WT+RT&QI%BR A+T+"MPO)ZA!RB#D-_XW:GYM
M&8C+>%+_&[OU[G?<0HWR532N\V8S2AIH^5&Z9QSN86QA%03W*&U\D_W1.E03
MA1+%W],J=%R'].7J9J2=)Q0CH9@)^=5_"9"$S(P8I0Q6U%Y6B7+37GL$,*#8FMF=(W[ZV60H();W!"^><
M__M9G'92O>F*,1-\"-[H8U@9TQX T)>*":H?9,L:>Z>42E!CE^H*=*L8+;Q)
M< "C* &"UDV8I7[O166IO!E>-^Q%!?HF!%5_3HS+[AC&X;CQ6E\KXS9 EH+)
M5]2"-;J63:!8>0R?XD-.G,(+?M6LT[-YX-C/4KZYQ8_B&$8.@7%V,2Z!VN'.
M9?>=#2UX
MPHODVE^#RTT;*49+& CZT8]UX\>NOT/@8-LVP,$ )T.,/S6@P8!6!M"3^;Z^
M44.S5,DNT"UU+SL^6+ER(38YT#Y-]8_+=J;M[CV+$YB"NPL:--!K3G/-IB*?
M*T@\28 %V*2 (T6_?((+"K2LD?04O:;Q&A0]HAANR?*%#&$$HZ]QT H'+7#P
ML@[I<="L3I+L]F1+E<]5&.]0\C4,7L'@!E8EC@B'>;^+,=?O8 OT'
M#UGQD 5/LOFNR)R'P!TFF[I\H8-[E&"X @*SS[FE5_:3JFO=Z. LC?TS_&=<
M2FF838L>;%QE#ZQIP5EIW/31M=__P_W"R'8\D:9C,?L+4$L#!!0    ( #A(
MK4@K&PO=V]R:W-H965T[#2E4?ML].&()5VT-M)W3_?GT!2BO4%SPS
M/N?XS&"7 YI7VP$X\JZDM@?:.=?O&;.G#A2W-]B#]CLM&L6=3\V9V=X ;R))
M259DV8XI+C2MREA[,E6)%R>%AB=#[$4I;OX]@,3A0',Z%9[%N7.AP*J2S;Q&
M*-!6H"8&V@.]S_=U$1 1\%? 8!H0O=';J%&^2(:UWFS&24-M/PBW3,.OV!L81L$3RAM
M_)+3Q3I4$X42Q=_3*G1PTT0\;L]"6'-'Y
M"<=QM(@.O$YVLZ6D\Q=_3B2T+H1W/C;I+J3$83_=[/EY5?\!4$L#!!0    (
M #A(K4B21=S>#P(  +P%   9    >&PO=V]R:W-H965TNX39!#X((?
MC(O [/#!2RZ$"V03OP\Q;RF=,9Y?H__PI[7T>Z9Y*<7?^F@J"XL2<.0G=A'F
M5?8_^7 $Z@(>I-#^"PX7;61SM22@89]AK%L_]N'/"@VV>0,9#&0TC'GF#>E@
M2&\&7SH8R/RYOC/#BES)'NB.NLV2I!F>4Y6QBM#U*JK:ES2+.YK%A.8N#PTTBR@/QHAB.B6ADT1HA=$L3RPCZ9H^ALGN8+()3#I[55E^78L(O_4$L#!!0    ( #A(
MK4C4$.O*^P$  +L%   9    >&PO=V]R:W-H965T
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MZQN6N,@YZY%HL?[8FYV"E^I,J.J]V&1Q[M^UT( )#>;H8":$
MK]17+4+/I8KAF<'(0K\\=HM'!;@^1TT3B>EC,T<6DSTWBA4GL"&2K)BYF
M^]PD69@DCL"K:Y):$XMIQFZ#('CNDRY\TKG/-G!]$NN3SGSB2!FMI3E]C?HR
M3+8(DSEA-JM-9S.;]2#K"!O"GUT*"OQFAH5 )>L::?^P4W6:1X=07ZI%_:CF
ME!TK#YDB;_$-?F%^JQN!SDRJ*VONUY4Q"2I:\*).M%*3=-H0N$K]F.FCML/%
M;B1KQU$YS>OB/U!+ P04    "  X2*U(0N3U(E4"  #>!P  &0   'AL+W=O
MTY96,RHNT';V[1?0=M#0:6_DC]_Y^!W$0W'FXEW6C*G@HVM[N0IKI8;G
M*)+;FG54/O&!]?K-GHN.*CT4AT@.@M&=#>K:" & HXXV?5@6=NY5E 4_JK;I
MV:L(Y+'KJ/BW9BT_KT(87B;>FD.MS$14%M$U;M=TK)<-[P/!]JOP!3Y7T$JL
MXG?#SM+I!P9^P_F[&?SFQ56_\_(--.:3&<,M;:9_!]B@5[RXA8=#1
MC[%M>MN>QS<)GL+\ 6@*0-< F'P9$$\!\2(@&LEL7M^HHF4A^#F0 S5?&SYK
MN3 FVCF0UDV,VZ4SDWKV5,(,%=')&$T:9#5K5^-55*XBA5=)I &\%.A",0Y?
MT(PBOF\0+PSBF4$RA\1C&J.FMYH$Y GPJ2I7A3$ X#Y,LH!)9C#I?8-T89!^
ME4TZ9I.ZG)G+Z:@J5Y6AA[+!"Q@\@\%>&.PL$Y/T%HTK0T;U  Y9X) 9#O'B
M$'<=0/ -G+D,YX3,^Y
M8MH-/.GMJ/5E>QVT;*],EYA]&J^?<:#X<+E-KU=Z^1]02P,$%     @ .$BM
M2#/<'I00$P  H44  !0   !X;"]S:&%R9613=')I;F=S+GAM;.U%P&TKFX$^4E*Y6NFD)A'D)D*!5MBE0QR$RKG^H?YFF 
MGN^8]_F4^I(Y]T9PD4C*2E<7,#.H!R,E,9:[WW-O!/W2F%1DD?XY4V=Q%J7?
M/.E->T_$YU48F6^>+--T_>+Y<^,OU4J:3KQ6$9XLXF0E4WQ-[IZ;=:)D8)9*
MI:OP>;_;'3U?21T]>?72Z%P^?2>3CACT/-'O]D;UAYN.Z+8\="3<
MJ#MMTD2"L/=RI79'?7Q_=7MQ+MY\/+TYOSI]+Z[>G[4L= ;>$AF"IT!]%M^J
MS>ZXVT0&.KH3L\UJ'H>[3[.[W5_.LB0A>5UJXV/='Y5,2 ;B7*8U,H^/>_WC
M0:^%M$L=JD2<8=Y=G-3HFJUD2,]OU#I.4J+P+%ZM950;F#/JZ"K'SU*99C7%
M_5C7I5OA^SB$@"0II'GO"YE$D*<1X WB8.]B_Q%'KZ71/@OG7(<9FP-Y
M5Q"'H4SL!!Y9LXT?E+Y;8KR0]Q#8G7(.*7[]Y=_%O%@TL(ON\]AM\Z0HEJ@E
MU*3OU:.,U:K'WYK?HJR/$;)>J/\&PNZ0[03$L9+))Y7*>0A&E)\E.M5@)L '
MV.&:7;1%H]!%;E@B4:$D=M-8Q*WD'$ZX)R+%?H(]ZB[TY95?RU!&OD((17XW
MXBA/ B[D'"+5<^6WAX!\/6D,UJ][N33617WZH'[.]#W\'8INB#-UX=41HG9!1'V+0FI^M$K:4N0PPOZVQ@2TIM$_=X-L&Y%V8M??7-
M$^C/7DEZJI:*.RT=ZD\)'Z!) J"Z<83ZY @%H=.:(]C;$W+;_%X][=+
MZ4-8FW(6K['0G].L 2R^SG3(>9T&Z17%1AL0FHE?[R.O1ITRYH6 [62KS/IF
MH"!#7W.,_XH-V.::7=A*T]I'34RW'VY/WXK3V>SB=M9JVFNY(;MN>)YDZHOY
MBQ7>ML:YOMZ=1&;/9N('UH3T5^PV &<@C7GNAUO6Z7_[E\\B]B
MZ)U,A]Z@-\U3D"9P&5@/K*#&KW3]JNT<'M1O$,\T(5WE)IMY^W5
MZ>NKMU>W5QW/WY]#CBZEO1DJ5(-
M7&KV)(7&4%S$X'VZ]4J]'H@SMF<[#9<6L0]9-$YUQO'8:?%AY<<.F*&\=PFQ
MF,,@#(]?\/@J%B7;]5/X+WECS75.@[]FQKDC< =4$L,3D4JC @_2[_2-\S!#
M3Q3E8KXY;(/S2L!DEY$K*B'_UAA!;W)@%<;&$+ BB$^RT 5 ;H#S/B(^T@6&
MS25%Z'E]T!$<%:C-J&?$%'_"!\L2-)&%S :+S5]*A"-#CRL,VN!,]%=B6UV:
M==/>@P4>@0*:4^W[0[7R)5.QXOV2J?@(+T:S(B'K1R52@ )?JF[2"^0?JCC:#V1Y'V-E0E=4O X1F?_M,)#<
MZS3PC:Q'D?CX32:30$N0#P35$4=P5-2O?W>=M%]_^4]8#U0'C!#*!RJ7_3A9
MQ[8](-*E!!A,ETF?"3*%C!T6WR27*S7.-/S8[.B' USN /&R$V;X%O&X(3::P ,JYU6?6%/G#=(/- J291%>&=QI-
MK7\LJ*G ";!J W5@X@95%/UX_?8[S;M!HRD<;86B(S<[LY6;2==.T<**":';
M5D]<-R8!PZ8'#3F^41$B(E[KR'DD[$S>*6MSX$[($DFPL4*LO#0<6X62Z._II%/@N8#9=(>.2J5,W9RH7@
M4Y:(TRB"AMW!0=7,OJUQJ1K*J>8@,4 ^ NP+@8HXWNR88=41R :TJ:SCR%E*
M4HQ0BX7R6>K6_4D'98=GIV'=$>=)0"*6I,+A53O1VV+64=TC*]SK.
M3 CT:3(L6T#F!]AAX>16AG'M1*!3ZWZQ60UA5E?MA4;E$5GW.>H,9J?2?[S@
M ES,RA[P$8W([2 _#CQE-/^LBE\>;X;#3I58#@8<*+D\WDU2J/!-2Y>:PEJ@
MH.95[K>U!(:)HT-%VSCUB@>R@!#Q9!M;!M%J2*R!0W%
M.JYX*$$E,C(+*G6*"FO#Q,"Y$F0&A%$>(FV FJOT@5S(\D1] < 2#58!+"!?
MM@JO2BY#,3OZ>"ZI,E@!X6
MX%L,5K);\,942C[L,*7O@U'.F633E0VWG0\(C*IDXSPU4>H8FLP918Y)R-7@
M&E *&8R?Z+FM#9TFE]I?VJ $$\@7TM$Z P=YT62EPU5Q(41><1%3J\:\$/_]
M7^(M>3+* SJV?$^R
M"V(RGI.;LJOE::YN IY0FA%  %3FIP22$D84]IMGZPE!8IECL'',)7\9
M=7(CY&:HAKL0@CPH7GE,9J*.W=8<;6!=YH+QNH7@GDA^$C[DKCXGKFHG#&^HE-\'<@>F/(9#JU
M,AEUI]YDT+=?QKVI-QQW^8G9OTN6:
M!CZ=5+N6RO6X&+Q(YT0P4V5#>6L7JYK-<]'D<)!-D:I$C@%8(2O-PRY?.8]V
M,8M)\6Q]@&6W0-\\AJ2\+;G9,+:*([7)$QO_WA&-QZM% -7;H&A1U6S>$82R
MME1$O]]1SS9B9NM1@9LE)3*6="_@[_5X@CIX"\@X)R]PKJ2\KN!3%5S4$3O'
M]U5Q4? X:*>M70P!I@,.><11R$ZLHY:#F_+ ?EFY#$ 7!!C'-YJ(1?\Q8C0Q
M]( =^29[(6[D@Z!2GOI7%*,&W;$WZ%$8
M&0R&WJ#?%3_$R2<+^6)J#E#(G4Q/Q'"(<#.BYJ4V2W9CV_L2%%*'7G\X%=/>
MT!M.*$SW$'\GWO#$?NY/!]YHV-^BL)+"K&U#H0\V0OE\)ZJ\+N!\F$=W;'J!
MJ524:W,@ Q-W!8>7L'B@<$0JZ#YS&\/8YU5DO"F#Y;&.//77[@
M3I5=LM,@!5WE[;#S598!PYR@N+XAG%'P18V^/>+E;*,DX5PNFQV8HC[X*K[/
M.Z/ .G&H4E50LFFVZ!%;-#O<;=.]B/+9;[/I46=K&T94541$P:"\_ 6%%M4)
M=9#ID&/%DI&VZV+C!D4@FDBU=:>ZI#M[SVS7GF#EI@PFO")-FZL(-=XV0(H7
M"P*SL !9P9+E/1H'%,%^45QI-L 575\+]2?%6!:%$374^#F-#_([*+2OPU8/
M&LB01ME.%4-L:=YNMMA]TP*)"VJ8*'ILS0W"78FYE 67EH6J7'WFQI
M)/N+ ?MU<6 V=Y<0GHIQGS$@D.<)@-QHNIO,\Q3;RH:[0+G;,#-0:WE9#B 7
MJ)-R1F]"$'0 T%DD4[=#?O,O/\JL[+'=U2.\=2@^P+:37A>[@4UDCPO;^>N1W,&=T_T/&-GO<:BM:-6HL<=P%G572/F)RIU
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M("]I:D%>WM1_DVP%O*PVKW^2ITTY]
M2Y'?)[S(>^Y?#N5QE-% X&5G>A3![3V\G!=E*'^AZA"?][LB;CL?B
M6FZ2. Q=I6NC:-'O[W<'7F_:XQ)^>-++SYML=58.&W:]Z;!+L)SV9/A/FXG1
MA'^8]/G/500YL='U^D-OW(7(CW.A3WK>8#@08R!WA&9[_ZXF"0+N/:#/\83:
M(^/)B3?J#PXZ;!!'MY2KZG?"[*T*^[!V[<,'G,YL CJMM]LJQQ W[EZ7NX?U
M$Z\G'FT/?W2U_@]VM0ZIT5O-KVIB1>'N%2^$_8,,Z?]/N?ZHJN$@J1^(IYTO
M?:U"_@#P_TL!?&/:/]1P.#M5T<#7FL\.L
MTB^_:U
M.V+V>3.S+HV>%A7L.YM&+SF-ME'2G!(/UT[9TOZ^Z(;=6.=IO";+>\VRU4K:
M>^M-V^[9;BO!U5ZMW,YM=27M)+?F5TMT>_^^L2/Z&&E]K/;:MQ5:D^>A
M.?#+HJLEI2^]W?D/24BM[SG\?LFHYACMN>CQC:-&;>?E=>YD^UX+;5G7R]LD
M\-N\"U(=Y-&+1[[K3Q0=E7\6;Q)Z7P1)8W>G8:?;_?,AVWM<*)?U>0-IW[N7
M"*X;K^#WN)7R-9SNV?C47J?"CO:_!#@MWEQZQ$9[D-@*76KI\@ ?
MS>=LWQUMB]W72;Q G--\?9W 1.MRC  N@0#:EG*8I?[RXPY86= 0  S!(  !,     
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M;V-0&UL4$L! A0#%   
M  @ .$BM2$&Z8D4W @  YP@   T              ( !QPX  'AL+W-T>6QE
M"@  #P              
M@ $I$0  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ .$BM2"#N@.=O @  
MX0@  !@              ( !JA0  'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ .$BM2.8BON5,!   EQ,  !@             
M ( !Z!P  'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%   
M  @ .$BM2(H#^N2A 0  L0,  !@              ( !D"<  'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ .$BM2-XP/_FE 0  L0,  !D         
M     ( !JC(  'AL+W=O&PO=V]R:W-H
M965T&UL4$L!
M A0#%     @ .$BM2(1, V:D 0  L0,  !D              ( !/C@  'AL
M+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ .$BM
M2'L@] .F 0  L0,  !D              ( !T3T  'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ .$BM2%AR(HB/ 0  <@, 
M !D              ( !?$0  'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ .$BM2))%W-X/ @  O 4  !D             
M ( !)4H  'AL+W=O&PO=V]R:W-H965T
M&UL4$L! A0#
M%     @ .$BM2#/<'I00$P  H44  !0              ( !*5$  'AL+W-H
E87)E9%-T&UL4$L%!@     D "0 K@D  &MD      $!
 
end

/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){	
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}
		
	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};
	
Show.toggleNext = function( link ){
	var ref = link;
	
	do{
		ref = ref.nextSibling;	
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';
			
		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};

/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	 
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	
}



  3.4.0.3
  
  html
  22
  113
  1
  false
  5
  0
  false
  4
  
    
      false
      false
      R1.htm
      000 - Document - Document And Entity Information
      Sheet
      http://u-g.com/20160331/role/statement-document-and-entity-information
      Document And Entity Information
      Cover
      1
    
    
      false
      false
      R2.htm
      001 - Statement - Statements of Income (Unaudited)
      Sheet
      http://u-g.com/20160331/role/statement-statements-of-income-unaudited
      Statements of Income (Unaudited)
      Statements
      2
    
    
      false
      false
      R3.htm
      002 - Statement - Statements of Comprehensive Income (Unaudited)
      Sheet
      http://u-g.com/20160331/role/statement-statements-of-comprehensive-income-unaudited
      Statements of Comprehensive Income (Unaudited)
      Statements
      3
    
    
      false
      false
      R4.htm
      003 - Statement - Balance Sheets (Current Period Unaudited)
      Sheet
      http://u-g.com/20160331/role/statement-balance-sheets-current-period-unaudited
      Balance Sheets (Current Period Unaudited)
      Statements
      4
    
    
      false
      false
      R5.htm
      004 - Statement - Balance Sheets (Current Period Unaudited) (Parentheticals)
      Sheet
      http://u-g.com/20160331/role/statement-balance-sheets-current-period-unaudited-parentheticals
      Balance Sheets (Current Period Unaudited) (Parentheticals)
      Statements
      5
    
    
      false
      false
      R6.htm
      005 - Statement - Statements of Cash Flows (Unaudited)
      Sheet
      http://u-g.com/20160331/role/statement-statements-of-cash-flows-unaudited
      Statements of Cash Flows (Unaudited)
      Statements
      6
    
    
      false
      false
      R7.htm
      006 - Disclosure - Note 1 - Nature of Business
      Sheet
      http://u-g.com/20160331/role/statement-note-1-nature-of-business
      Note 1 - Nature of Business
      Notes
      7
    
    
      false
      false
      R8.htm
      007 - Disclosure - Note 2- Basis of Presentation
      Sheet
      http://u-g.com/20160331/role/statement-note-2-basis-of-presentation
      Note 2- Basis of Presentation
      Notes
      8
    
    
      false
      false
      R9.htm
      008 - Disclosure - Note 3 - Reclassification of Prior Presentation
      Sheet
      http://u-g.com/20160331/role/statement-note-3-reclassification-of-prior-presentation
      Note 3 - Reclassification of Prior Presentation
      Notes
      9
    
    
      false
      false
      R10.htm
      009 - Disclosure - Note 4 - Investments
      Sheet
      http://u-g.com/20160331/role/statement-note-4-investments
      Note 4 - Investments
      Notes
      10
    
    
      false
      false
      R11.htm
      010 - Disclosure - Note 5 - Inventories
      Sheet
      http://u-g.com/20160331/role/statement-note-5-inventories
      Note 5 - Inventories
      Notes
      11
    
    
      false
      false
      R12.htm
      011 - Disclosure - Note 6 - Income Taxes
      Sheet
      http://u-g.com/20160331/role/statement-note-6-income-taxes
      Note 6 - Income Taxes
      Notes
      12
    
    
      false
      false
      R13.htm
      012 - Disclosure - Note 7 - Comprehensive Income
      Sheet
      http://u-g.com/20160331/role/statement-note-7-comprehensive-income
      Note 7 - Comprehensive Income
      Notes
      13
    
    
      false
      false
      R14.htm
      013 - Disclosure - Note 8 - Defined Contribution Plan
      Sheet
      http://u-g.com/20160331/role/statement-note-8-defined-contribution-plan
      Note 8 - Defined Contribution Plan
      Notes
      14
    
    
      false
      false
      R15.htm
      014 - Document - Note 9 - Other Information
      Sheet
      http://u-g.com/20160331/role/statement-note-9-other-information
      Note 9 - Other Information
      Uncategorized
      15
    
    
      false
      false
      R16.htm
      015 - Disclosure - Note 4 - Investments (Tables)
      Sheet
      http://u-g.com/20160331/role/statement-note-4-investments-tables
      Note 4 - Investments (Tables)
      Uncategorized
      16
    
    
      false
      false
      R17.htm
      016 - Disclosure - Note 5 - Inventories (Tables)
      Sheet
      http://u-g.com/20160331/role/statement-note-5-inventories-tables
      Note 5 - Inventories (Tables)
      Uncategorized
      17
    
    
      false
      false
      R18.htm
      017 - Disclosure - Note 7 - Comprehensive Income (Tables)
      Sheet
      http://u-g.com/20160331/role/statement-note-7-comprehensive-income-tables
      Note 7 - Comprehensive Income (Tables)
      Uncategorized
      18
    
    
      false
      false
      R19.htm
      018 - Disclosure - Note 9 - Other Information (Tables)
      Sheet
      http://u-g.com/20160331/role/statement-note-9-other-information-tables
      Note 9 - Other Information (Tables)
      Uncategorized
      19
    
    
      false
      false
      R20.htm
      019 - Disclosure - Note 4 - Investments (Details Textual)
      Sheet
      http://u-g.com/20160331/role/statement-note-4-investments-details-textual
      Note 4 - Investments (Details Textual)
      Uncategorized
      20
    
    
      false
      false
      R21.htm
      020 - Disclosure - Note 4 - Available-for-sale Securities (Details)
      Sheet
      http://u-g.com/20160331/role/statement-note-4-availableforsale-securities-details
      Note 4 - Available-for-sale Securities (Details)
      Uncategorized
      21
    
    
      false
      false
      R22.htm
      021 - Disclosure - Note 5 - Inventories (Details Textual)
      Sheet
      http://u-g.com/20160331/role/statement-note-5-inventories-details-textual
      Note 5 - Inventories (Details Textual)
      Uncategorized
      22
    
    
      false
      false
      R23.htm
      022 - Disclosure - Note 5 - Summary of Inventories (Details)
      Sheet
      http://u-g.com/20160331/role/statement-note-5-summary-of-inventories-details
      Note 5 - Summary of Inventories (Details)
      Uncategorized
      23
    
    
      false
      false
      R24.htm
      023 - Disclosure - Note 6 - Income Taxes (Details Textual)
      Sheet
      http://u-g.com/20160331/role/statement-note-6-income-taxes-details-textual
      Note 6 - Income Taxes (Details Textual)
      Uncategorized
      24
    
    
      false
      false
      R25.htm
      024 - Disclosure - Note 7 - Accumulated Other Comprehensive Income (Details)
      Sheet
      http://u-g.com/20160331/role/statement-note-7-accumulated-other-comprehensive-income-details
      Note 7 - Accumulated Other Comprehensive Income (Details)
      Uncategorized
      25
    
    
      false
      false
      R26.htm
      025 - Disclosure - Note 8 - Defined Contribution Plan (Details Textual)
      Sheet
      http://u-g.com/20160331/role/statement-note-8-defined-contribution-plan-details-textual
      Note 8 - Defined Contribution Plan (Details Textual)
      Uncategorized
      26
    
    
      false
      false
      R27.htm
      026 - Disclosure - Note 9 - Accrued Expenses (Details)
      Sheet
      http://u-g.com/20160331/role/statement-note-9-accrued-expenses-details
      Note 9 - Accrued Expenses (Details)
      Uncategorized
      27
    
    
      false
      false
      All Reports
      Book
      All Reports
    
  
  
    ug-20160331.xml
    ug-20160331.xsd
    ug-20160331_cal.xml
    ug-20160331_def.xml
    ug-20160331_lab.xml
    ug-20160331_pre.xml
  
  
  
  true
  true

begin 644 0001171843-16-010026-xbrl.zip
M4$L#!!0    ( #A(K4B&^EZZC"T  &75 0 /    =6&UL
M[7UI<]M(DNCW%['_ :LW,^&. "7A73MK6R/<>G#H@HBI@& 0X.
M2=Q?OYE5  F2*)P\9?;$=(LD4'E45E965AX__]?+Q!>>2!1[8?#+F7PNG0DD
M&(:N%SS^O?S?PX&OY* 1$Y"7.%A)GP;IX%+HNMP0H1_
MO+__31@(DGDI&W>?A._?/@B*)!L#21_(RF#P[N>7A\CW+O'? L +XE_.QDDR
MO;RX>'Y^/L>OS\/H\4*1)/7""^+$"8;DC#UY.0S3((EF\S?HTS$9GC^&3Q?9
MC_"FK XD>:#*\]?2* )">.]EO^*+VO*++O'*WX$?2AXG+\-Q^?/X2\D+7O!$
MXJ3\%?9;"35>'&J*;%:QC3V1O^![P1\53^//#TX\9W+@>,.X'"?Z$Z(D+Z,4
MA$&03LIAN$ETD&L!3)/*&^7NQ-RP'!#^4@(F3:<1Y'GXI>2%A/^ L.:4CJ8L T'CPZSG3^W,B)'RB5
MV0\73-2+.*1)Q&6^?0&_Y@_B#^Z*O&7/&1?LQ^*C7HMU\[(F L\J?5JV;?N"
M_CI_-"Y[#D:5+_[QZ;>OPS&9.(.U\6.OS5OO_N/_"<+/"/4RIC_=DY% L;@<
M1V3TRUGZ.,@Y?_X2NV?9CRA&OYS%WF3JD[,+-@JLQ,NK"0E<^']RXSN/PC ,
M$O*2W.- [N_YA$AR]J=*Y\9S?SD;#F3M[-W(\6/R\\7:.(OA/U %D=QX\=#Q
M_TFO?N?
M#"1W0!Y,1*L]1.7L'7Y;!G,^X#I$ADX'QLHR@\>^78:Z-.@ZS&\@3JU 26?O
M9&GP/\M <)3%V!^#Q$MF'^#[R/%O0?F\_)7,V@ !]DGPCRS)BJTS2*5CKH$,
M)Y,P^)J$PS^^CIV(Q%_2!)<;;MY+\+W?\^U8 J N&7H36 &_G-U^OLEQL,^$
M-/#8XU35#&(ZY-D[3;34<1BEQKY&YWD.:@$U\0TB&48$_P(!*OYPYSO!W\#2A1E@^KK)+/Y> @$'PB5P]>+%@^L/
M^/$3F3R0J$"E+MMG[^[D?U)B>F%912L^_!&,E' &9R+>B%<3/*_ 8+@K7J7)
M.(R\_R7;H)XWY;HB\:9<-G4I$\@-TY?QC9G+*$_X5'SGS)P'GW1>7)9MRCQ:
M5,U2%/7GBVJ8W?"J6U: E\+#RS8L6>^&UCT9$N\)'_M,DAY,,TRN (#U86KF
M.GIEH/L@6<]!@ZN8;%4S=:TCCJC'WH=!&O?3Z=SI5?,E5 6R$U8-=+G&U>6(
M5">L;@,X$)-OSDL/?L%RT+D2I\F6I:YAM@ZV,W9SOA70X6W)PDM\&7C^+V<)
MC)Z?-==@QFF$!]H>\L-7#[*BF9)=PH]EH!TQ6^,%H,(3FB:\^,US'CS?2[Q^
MTJ%RN2%+DEDB'NMP.Z/70)=SEY5IZ8;2&;N[*!R1&+VNCM_$QOS]QO&BOSE^
M2M[/5S3
MVS#*].%6R&LW>ZGK)3!7O<")J[(KYV
M&A63N[!U6]$U99?$?TG&)$*O5T3&)(B])\(,KM_". 8;^\L(+*\NHJK:W!U5
M40VYE,(FN&R8$*V6$(VO"W3;,LKG:@^4U&LUC6^AFXID&)NBQ/?#9S11;\+H
M.DP?DE'JKY_?^IQMN:)E&4N'QC:(;)2&!@8G?P/<& UQ3)*XBW*V^,:Z*9F*
M)167+X72#'*]9K2XQJJL&Y:UO/5R(7??^16^.2GKM@K'&'T5@0K>=]_IE0K_
M#>SSIFU(S?!X6K)= ]U_<85%^\GY5QCA15C\971-
M'O(])9D51D(#\,9[R8_JBU_JS$#5KK!G--NTE>)*:$;*GNAG7\*O5%]^2A,X
MP=RD@=N !WPK7[?TI:/G/CA0L9](_,4JPW+5EIR,.\4]/[1L57HUF>\ M@W+
MUJQC(;^S\&HR7W@UR;+VMGSK[5.%+[R2(=F6JFP-]Q[;$]_]*\N:;,IZ(W71
M_S6"X^;W("*.C]KV5\<+
M\  J-[I3W_)RKW! &W;9+M*8NH/B3@_%P+?R;4V2RXR$@V)1%6G\T!I#,J4R
M3;]'TO0%:3M2D-RU,3"L92_@<;.GAS+E+P[3M&W[T%E411IW<D[DVL'OBYWCJ#///&4PV#!M!^$9!? 80]PA"9%^(PE<2>:.WPL2)'KU@
MD(332P$>GW_Q$"9).,F^>_;<9'PIF)(T?7E+<1+8/Q2U*(?[1. 0,W3\ 3#Y
M,0#JPNGB8?JHFS^:C2C-";Q(W.I'%3-CAW(N5+^ $Y:C\*\T3KS1C+Y(9U<(
M1\)=1&(P&NA-Q\I0[&.T-/(%93[[:F5V6S.:,E20W@H\)/_B3*9O@X=XRK@"
ML#8*F/X;6Z"9\O!FP8F(,(W(%/[K
M@H0+#JR0!@Z@/V\"Z.^QV6.3R#
M$=J$ KNBV4".\(;RY?^_P+(;OOWUZNIN\=E]^Q-P(X(A5O'V OA^0J=9%*9I
M%*<.6+Q)2$%%!'1ME)&%[T?SX.TP$,#0G @8RB\X@2O\Q8!QA*^#?YP+
MMPS;<.H%^!W@"7QW'NE@H@#T"HZ++*6#BZA$0/+HT''H$^ &O!$@:CY Q>PR
M_,G!JU;0?]GS+D&>!F1(XMB)9A1%!#IRO AY/I=@'*QTKO(WC#+,# QN%SGP0)G,$09W!<"[,
M5>+!\#!&/EPR=A(!_@+EGB#M$V<&T('>@$0$@+(4XI:W@JP O^4(S(@3
M"82E*UP#5-P0!546:?(@HR!_.0T&F52/V\
MJ!**?R]VP+4=;&6#2ST?&1B#B7$[F4;A$T.>;H^=[M^Y5SR*:1J&5#BW5,+N
MA6:#FW)^N&,/-#\X\1B>PO^@X?8$%@<\>)5\<*)H!D/0.)=.[KF*F#]#5J6"
MR=,(AXV@WB(V"6W:X1$M;CQ[+9I
M:O8VL&:)#7!\ RT9$]!/]+_]SKXJ-\+VG6Q)EEPK-.5(;9*!
M+&FZ94L;(2B<3#QF7^  (=7U!/8D4J7&NZ*:A
M;0A;."I_ RS?^S ;;?VLUD'X68_%RSIWG9KGW3RG2],GL/G;C^.TVG^9?>D%
M+L'1!W/"]^]5+81"9YZNX1)3/P/Q+?ACC;V& \/\@
M3%KC^2T'2'B2NV@CPH EH!#(:$2&R?D>:.\Z(YDNEQIJN
MDC2VF,<.'-JHR[THE/3&4>"N]*+7L: _:BDLF^R2]V&:8#:#7\[4L[JQ-LN-
MNN$H%K!7ALP??BG0>F'T-_K^)R<:CN=N:)Z#]L2V%;:M^;:;P+*,$ +
M_\'Q\>JK9K*S >4_-YSCU=H#WQ$]^<>,! "C0EAIBAZXWH[1Y>
M"@[FEH;SPF%4JUGM)TKE\RC+DJAGBF73D/=.W!O9LD5;4KN _FGO.G45K;="
M9MK-[2 Y,Q/O@_!6$=2&E>$,+YSR\46]@<]>PD(=9XPFL
MMO#ZJM$VHQ?%1Q(M6=H&YFO2]2/P$W9.NT[3;!COW6PCJ[.EG"MZ-F$?F5LS
M,WJ:; D-!NTW3VP@P0U3V,@Z&@AM!RYL.&! 28:Q+<0;L^:5LK>1>;H%[JXN
MM'+?5G583IW_<]5;&B=?1O?DB01IS]MU6N2;DV1AFZ:B%W$L0&V%4"OW,C_5
M3S9,6Y&4QACA'?3'ERDPE30L6\I%2N%'KNB:8A4S4%42JF'-QB4ZZS'?"+'K6F,CQ"J2;G E<&O$-JP,N[,IEQ7=XM[0UG.@(3G;
M9^_)85MIW("?LH#'PO9H35H]:2AE66OMHD^+<8PM:+AQGM)4@Q'+)3PZY[KP;<4
M9 O^5]@.N' [H]<@QX-OM'.*?#^RSP[ZCV]("F4
MEO[D!6'D)3.:1$=B3/1='H5E^'XBR1A#O+&!%\L>ZKDBN'NT";]KA26P0YH.
MB)GMEB97SA59MK6BG.^9FS @6E9^&(,T=PZF,T_!=%V"Z8R.P71LZ@0J#*<@
MNE9!=-\6J<>+_%_[;4R#W#!5S\/2SH(7"]BNT,6+0@_4 79EF=!;0(Q227+'\W3FH=L(6,J9RB,4LQ?CO(C+AT17WL@ 5CWF-_[//:&8YH1
M&XY&,4FPX:4C/#E^RDQ;)R^^F><> WEHI]',6"]!?"=XS^Y[?V""+'P=T-Q:
M^CL^[V;^% K7854QGSW?IT^QI%5Z2WHN7-'TW;7H&AH\N!RJ)"XE35YE
MN<'X!88?SMT117(;)*%6*2>.&LN\EN\9D+Z[(=<2 +/+UM?T]QK\CDBVVV6X
M+F<#D\0Z(TG ,/=Z6M@JOW*K5LH^!K0E1JT.>/R*KFHIKS@8+:74W08K+75Z
MI-TQY9<(W@_>BYG!?GO.[.AF27J!HFJU7KK\6&-]AI1_/S6_W,G,DKU964JV] ^_Y?EP5
M3*8J0II@MQT*VTT6OY:=HE2OZ0U22/5EW[GB5SJP==.H-'>*:/1#N1WSN6[N
M@0$KI2O&; 7--N"+T0_"%W,\!>3FSHFUZ,NFSIBY][email protected]*W.NZE4N$)X3
MYG5FSFTP&+]YJM3<3X)O/D3"!1WKP!*H.F2;;9I/12_3@;-JJ^EEAR&U;[[G
M1>]X$?@;AWC%@;>1;0YQYY8(?5!&T?;"J@*IFB*BL]\3C^E$A5U415J4L7.K:4
M2*[L_CV,_L#T^&D48G'37@M^BSF AB%:M5E'1YK?J&FBI=:ETNQ)RC:;YLB5
MPALO\.(Q<5$,W728Q$++O)]7D5DGB[(.K-;J\K&WB_NK9*TM:Z)F==@(-QXQ'!@RF)\* Z
MQ*:"832OG<^J;+"GSP7:5ZX@QT!2,2: _Q)D41)DD1:]YXX,!XK^,^^B(&#
MPB1\HFT18/CP ?LF)&2.R:Q1%!+?+<]QX.>D_QJ&+NM*?<]0[A(OK:G\IH68
M5;I\W5"+P090;M!MG7LY!<8"V J;P!B>Z503GY^A !L:[&F#SF^%Q+WS_"EWD?27-GX@C&2J&.AF7K)7CR
MX6\ X0;RR<^'TRRU3-NT09@%]<]+YO8M7\#5C<#WU:6_ KH#;NU*&'!5IJYJ
MNM8)M_@VR+KH?9K7+5OKIQ>X'^ TZ7C!M\C!G%%D H&>MS&_ A]Q6&NO!Y(\8R>T[&0V=5"\/: 9$QT6
MLS+_ZRH6XG0X%HL4P!'.R088L+R3"7%0PTSF21Z+_F+%HUJ>HP)$I),IJZQ(
M'R_!)F-#&A-V,^$-V>%HP8$YN3S$'83HL8YN>8LYVI,NQ4/E H?ES) T\3"W
MA,U+,HX(&,O =V#LWFFYY9 6',>IL/Y 73%(A*
M8R8JC&&(S(*O=$1VS1M?;G==U"["5ZF9-;VP]]0J9]DJ/-UX[_LZFSR$_H*_
M$\]UP_H0C.P&J@VD^CB2W\@3\0596&@S]6TNB%EBUB)GBWE#0C]\9%TN_YV&
M"?6)>&#="6_2@'5X)&[6?!)5.K(_3\\J+$B/%=MV6,896]LE:50[WZQ.4O_C
M2+W27NJSYJ KDD_=CJB(YK=SJ>K#])]@Z-:)]1MFGS%V8/F"GF\2CG6:I^S,%\P WVGFXT'K'SF-8
M@16N<;NM9_RTFE_-:E:[[6%I4%ASN"1CX#*MZKUHBURP:PM6[#&LE1T>E/+8
M0\')&\X/0 \-:%'JQ9$HMWWSGBZT,72[4Y5(YRTB@VPNZ!&G,$5X>"BTD&;V
M/EO+IMJ4V8-Q_MJ"WJO#FYKHDV>"M]$(P'??;B2&
MNEF;DV:1WRN>K]7 Y68M4[I'Y!1"<'<4 W3 $+N$X_0/L+S*U28SWT!M\J*X
M:T+0=]DAIVZ)X'5^"P$^ HIN<*.AC1(/BZY%&Q-\M7':21VYO]*6*%B&J5(1
M=5DRFXB_U_4&\??*(GKTA;K6:*VA29I@V9L10#_:6'Q9$C7;%&U%ZXG*\8?C
M8V,;0Q,-N2Z&[_6SPC!$P]Y>@L:FUGK7Q(2*./'Y2F<7GRQ.BKI*6JSV5QG7
M;.B6J"MUK9%. >.M&6OIBJBKYHFQ&T]RL#[email protected]&]LQYR"\ODQXYCF
M8HB:UFEQG:+R&W%8DTW@@XKAB2:TA[22O9CI.W3&]>X>VXWA]Q5
M0E4;?JO ZOGQ-O0"+JNPO7X;&1
M2FB[[email protected];,_@B,M60+&'NZH]G\58)IBK:]XVI)N[%>3O<'
M?.^V)!J2+5KJ'HK._# <-F5;U,RZ*H@G#G?FL"T::IU1_NJJ)G6L][U3)&ZR
M_!Q:2TCX=^I$"2MP1 L H:5(A& .NFX$)!AA)VT"IRFG[_&(*Q%-"Y7L\CP62-H>_$L3?R6*I\
ML:#7>BI*L;S74J9^EA\2D6D8)?.R95Y4K !P+BRB;-?D!_-..L)>@AMCC8!T
MDOJT3A@[5W$ Z:25$HJSO5(&@2;HQ%,R
MQ#2K+)<&$ZY8\0%,UVE8R6P;A4^6RZO\AM1U*,QE< N\&/92!2($T 1D@U;/
M_'YUM2 7B:K J*\%:H997&FS+4LM]CFJPV>Q:!?+
M-59Y)\<.+Q
M';;\=8G[?O8]QDZ 3%&BRL,$138/)3VY>_:],OGMUG10AT:AF%D_/+=+ JL:MB*@KNE3;
M%)F[S6J&J1?+J:Y!;HU8NX*!W.T6N&4K9GO$-B5:BL)7"+)M*G8):K73N2DQ
M4Q3NTE5H&=.R&>5B%STZ$@LY .$WYP&?8C7;@48OAA=$7&:LI#NN
M82SI(.95WD&O/!$_G.(*%H&^(!TYPX35Y*,N0&K[XR=6UWX"'X:PV!XCXGJX
MZD6LX!Z' 18*@>?'<"Y(QL(0<:.$.24@E&7R.\C;5%%H_@R_!I
M"I@G3C1CSA,8"PM2N3>K.^AP&P\Y,5"RNC6A*FKS&Q!6(G9"J
M]VI97#O1U.2BVZ,I4A^*KM3%5O^>C,*(W)/&-5.:+C^(T5=TXS[8]/B_N>_0Q]-X=S%
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MLL%%KFCKVY>V)Q_'G RNZM%4^
M;%?%5:X=. HED?>0TBO$$>'*ZMY5A"*9HE$[!T>J_Q3)$&VS+O'^T)5?*7YW
MSBP*?3]+06$A^*1H'Q_D=*BB;-?E_Q^IK&%FG:9OF+@]:K"K(,"T&99' PA;!SS>VDDM5GZ"6Y_R6YB M5IZ4_#C%?D094D2S6Z5
MGTY55.H9;%JZ:'1K?K++*BK%OU?" JIO[9>O^>^<&8W3_A9>#?^=>A$I2U'M
MF^[)C?$T)-W2"O%5C;#9" 'MY@72*I:M&,>1P$Q3<1>$45._LSL= ^<#%
M3'&:5M W&Y,;F:0O1;DU1VASA+3+L>1FWBER,8"_,R$844/S&^AZN@OC)"*)
MQSKYOBL*0(9M/._?]9CM2WMS_B9
M.,-Q_EJAN XVCIXZ,P;6BQ%U$F&;Z(<9'2)_XUSXF/T5"P^$57Q*L6@4IN33
MTD0U. %[1K3F5T"$&7%H\2_V!FT/+MP& B[5A&:9%7I<"V,'(1+L&0WV+P[[
M)YG=,6*^&!LK"9^=R*6O39G.P^&!<:"C4'.% 2:"9;.SQ*F<;F>*KF#X!JL*
M34+,6?/].?5QU@/;64JV U"@"P;PG^5B1*&".\RY4%J0;?W!I9EP/5<(P@3F]P\L0C5;86\5@@W2[+IN.BM;
M5T2FCN=F9Z1\,);JU#UG3C&X*>6*I)I&(3"U 0(;P+@^%\S@9U&!U:FJ_3'^
MYKRL6);>VCZ?X<(S@"M+M%2#:< !KM5JZV:QZ$X1T"H*X9 0-\:4&,R%H66S
M,*.DP*]<8$M:TEJ S0!=!\D&Z3!
M1+-F&+'=%DN7 P\YY':8/"9@_61)WPU5?J.?".XC6K8X6&+0K,,.=5F"V
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MM)/&)4
M8M$+X7;EHOA5R0PL>]D185Q%Q/WH1 %,8WRU*.^+[JNAUZDBJ,4W6S3=U.6B
M'5B/07^,&]18Y=LPFJ1+8!-VQQ@M_O@>)B)(R:J)U:$,'+\8 1S\X*2U0'0%
M<$NL6@FGS#7\-=545%MMBM5P3-P4JR"L5YCYAIM3KH:6O&)0'#I8>2"LRVDJ?KTSBXKS1
M)#RF_-56*6SMH+>BX#!H+DE7VQ3-&U<\W9/3]KJ82[+1CE,KE62>';Q*ZI5G
MMF=NKR66':?8E"21[55LVNF5^I2QO3)W/4?L.(5D/1_L.%5+:?;7?CF[ENYU
MG!*RGMIUF%JD52)7LU?WH;37,[XVK,/%V--;O  259J:$;73$L
ML;*2'!;E,G:"1]JF6"A(@L!*K2[)@L"$H2B'S6RLW5^SM.1!W7 ]+Z=.S&IW
MQ;6EZZYV]QP/'H!QF0  +_ZS'=@]P&F(JI&A:_N55Z!V*)E5!QUC^4*
M9*7O>M[[/ RR'ERK/>&MZ$[+P?C_Y%E2=3EBG/+L3BRWLB6
M+=I2A;58"O"G?6BZ^C-6?A">-[S/I(Y*8-;K'D6I('?+(;$8H>H4;(J0VA3#
M)9O"6]@4K_UT_@;$W)(K_)R=\%T3GE?).]B[7H-CH^)H_#%P"U9%C:)^E4=M
M&2P4R3!.7HL->"UJ;+U#B8HM#BV[[[=X6%<:(3=RD2]^1XX> M,W)^:'>P[[<"-(XA?
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MM.V*B/@#+>AL\D2 )HUG6;Z5'S*EQBCDM[@"]#]K-P\#FH:3X9N,H
ML!WG4[9+.=T@=XIW(0?.H*WDF.Y)*%>#D+<&YXH#I0^/@
M3\)GT#HEL;A]R=I\;>>N4/:=Q,SU+M\[S]CF#U:=XQ^/[TR53%&5MQ+B=[@T
MJYJH*L==V)4KAG\/HS\$VG0E')+X<*HQ&H9H564@'LM]@*;!.;$B,.10+\_:
M>A_EQ?U X,5@E:-$N>DPB4ONS%ZCHT>4=6"KMCM7SZMDHRUKHF:U#:0Z^N[EXJITR*ZZ4OGUHR2
M%5WE=L@2IW'LGG%!TG7T9?QTY$OJ1)
MG#BT_,-[)_:&V%/-\],D:S=?ZR;D=LQ2BTU)7QXBWQO$"# ^>Z?IMJ;*]H**
M;@ANA\A6;<%4NXI(0U,W1*3O!7]#28 H;3 5,V!0\EV3?+8T$0H -)L-H_F-;7M,W+JI&+("[)D$X\8)J@'6<
M686X/FC^:X%N'CNSY4+#[=_!>T)_\B2K-AZCM3BY14"EF!ED%@KU57XL'JCY-I)R+L%#?DHB]]6
M7H)%6'@%:5T =@LOY-\60.=?9?QKR=+?L8]C0-P/\&C>W 9;5G]V)N3JQ8L'
MUQ_PXR?J8=\#_Q=L)8_8VG-56%U XV7J8RM*AJ/@>A,LVQ(&OYSE^K:&QK-W
MZ>-ED4Z&S=K0:S*_C-,K%A5FH/P8JX_2NB.6_O[)^5<8?8.M./XRNB8/>:/X
M9+:X]:6KD'T)O]+J1)]HX-H-QJT=]\)L2#Y=H#4L.)XU>Y "1L.76:&KQ2\_
MBG!E+U3PX"1=I6>^H]L1C/8L-;:XR:ZS]&2/'8H]=OBBCMIX>#T"=C(>
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M,2YX]#S5- 2;1-'
MHER2RJ6_OD-*LB69EF19[6Y@/T41Y\IO.!R.)%_\\AH&Z)D*R2)^Z?0/>PZB
MW(M\QJ>7SM7EY.31LD9@";6_@ZN$QD30CYX1Y
MTJ["#&D-_:(&'G$>AW8=OA*N>IM3%X@P4%'!O 5?/5.103+/;AD,6.R2:B[6
MT,.(A2&>+LAC/#WTHE 3G?8&.1*)IX3,%W03(L?&YG3 34*R(%5B$0546GG,
MB)U)SX"=R8Q8F+2/?BD^4J!/W&0P3\HJPH)QJ0CW%F'QNA)&+P-#W3\[.W/-
MZ()4^C9"$-MW?__\Z12*\H1,2!V!ZS/^,2< FC/J0(P(:
M4JX*!+EA1<24JB\DI')./+H>NZO__("020\LG$="(;["4Q-_25KY%'E$F136
MA N#QV
MBFEGSTJ:;&++@LEMMJ%BR!$ 6N-L'2(-%N%K<1_](^
M=&LWUT:!DN/+_L%+(>V,*>\.30S)>/0%7C*WCI%\1FT"BF'1_^&,3V,RT)AL
M8$7U3M,^G1A96Z<32\G2!)H<6WJ]=824Z[,F9F0\^F+K3+92D#2*T8S)7+6)
MTIKRKHD12Z[DLK49*X5*PV62,>CU<=)J9:S4;>T7AKY3L2X(YY$R0LV][.Y\
MSO@D2F_!35U-G6>%^2.=(%-?G1/AZ857786YE<1FOWD(N'0DS'M#4YW_9&8\$FSH#
M+%X<&$2^2Y=\.MG4)6!AG'VW'LT%W=0C8)%P#&B%DA8P @+$X% "&ZDR)PKL
M1UYL+@CW,?QEZ@WK-2A"H\5!FN_KX_W:,T5B67.!"[,RPY8P)<>F)D?TJUZO
MAS"Z277E+X?<1[=&+;I?JKUP2[I6S(@E]7_C5^:ZM!A2YI2BBK$85W!VP=,GS)5^6N)H@D@J]6B
M@Z^9WI_V "> P+R KAGEDCW3SN&ND=X5^$>5X%_GC=B'0BX4QB0P!R0YHQ0 
M2]H+"L.>Q")_FRAH*KBK !B4 N!CHA\]&?WHX#HQ #T8 ] >^\80X3G1]V=4
M,?!>_F.A4-;3560ZDF?2"R()*N"?+Z 2
MZ5KPBU&J ?Z8*MUQ2(\@$TMF5EM>54M4UTGK"M@/5F"/=/X&M1K6AYS:'8=V
M@ 7U B(EF["D\Y;@PB+1!=:-Q7<%_L]6\'6-]U@R) D$,&0?#DN\CG'2W#=;
M7$O,BS*Z O;,"JPNT>Z7VG8OV=%[R1%+]6VX^B=
M9DT.15Y;PU<2TA5^?2M^IP8_TQ,9:74[#N ':\^J)9!KA'4%Z)$54%TZV5I>
M.P[LS]A81GW A"\=Q/L.1
MFE&QW4.IM9*ZPO6X^#3*H*JKH]^TQOV#*'L="OOA.&B]JUI%=87G29/*%AV,
MC-9=[RX5RM/M0+6*Z@I4>W>I5/#N0:VJ=;9#MUIF5S#;>TWKRJ@]WFMWQ^W 
MKA#8%=+VQI)UW]W#;-LU?:H("R#1TE<5DZ"3G;@LLRNP&S6;T,%-HAZ-$O5[
MO,DSS(>.?5@+D@042^K%@NFWU#*L6N/>1'9'^!_9VU4:_V%F!08SL+8#/2WL
M6$3$KD="L;3J9N57R^P*>7NC:Z5NVZ_\$C8R#D,BWI+W]%9@:@UYC=BN4+=W
MP\S#_\2 Y$7 U0#8=>"+[>:.5GJ-T*Y M_?'RCWM_5I?.5@1SXM#[1/UT[K;
M>M3:;NUOK*:KL#A>>Z0;+@U*BW[[(6^?&^IZW!TEBDTT=!4>]FY=95=]GT)6
MCNNPMD4,N-'7.2R>K0N%"H%=X6YOZ)TE:4&K1K>IZIU( !=N^2.Z]$[Q8SOS
MJ5WZBP*(C*42Q%.7CH()&4(_%LFC&W=C9_2[H'>4VATI#WXS)XI&0W@O$A>8)]/WFTO6KZ=JXT9R
M)XPX+!GQ5O8C?0'\TO$$A3FSN9=\J:[email protected]?E(C*E>]\:D'0KR>\D.O<(
MJJ]@GO(#VO#_4K"/3Y,7T1<^;2FD/9R9A]W/@K;S-IP'T1L5:YT9AOHW#,"/
M_U$BAK&:P9GM+UHU+UN*_0<#WZ=C>]RWR$W90^,A]V_-5XOW^>?14T[3W
M5"<-/MTR(F[_C,$DL,V4WY]C74S=Q=R7Q=5<3_:];1NZF!A%=XP#ZHP$B\\,
MTDIBE)7)B7^-J;\57!5>2IOA,N_96HIWX\TP9:CW*D?YG7EG^=QFHRY_XOG6
M4M[/K-A>-JF=!"O3>_'9_BY&C<]KF-Z/SW6=[EK_:P6\E[G8O!-8,S5_:U7J]W56AQ\>HS"U@2XH"P^;'>WMMLMB'T6T/CN
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M4<)*B""6WH"$6FY/C "D\/R$3H02C&[XF66WLV?VN_YY7][OL^26(HK,B6#
M$(XS 6?RA&0 H5(UBC@3/M0&QWBNR'J$OP8?Z$2+] 4D#D(92R- > +!N7)I
M$7PECR J4933-P:A3\F AE12) 0S?2,0DDA/> A.8,S!I^G<5W^'H/_HQ4$O
M8ES2[^GU*\[4/);3*S7%I;KW^;^$CJ-2Q"L=OE$%7)F4\)5S+%Y- V(.B$TU*[VE/$;$L(-
MJ'40XR*P?/5#.DIHJ(-/H2;FN3)?-DG7>W'&E>4:X*!XZH=R3,1(2:1_:1%\JL3]FX0)&"!9\38 C441E:F2M90LEDHFE3V*?TD>9A2JI0&[KFGKO*'I;3UBW[%
M84QH\/EQK#(.4,90D*_\ 5AP-@8K+0:4R_^"I E!#7EMF2O',3D$QNS?,2SU
M [D&26@,P6?"XS1'*18KAM2G)CAXQOI!H5>'Q=:#0GVXQ_T6XXK]L+W=;CT 
MO1O)?)\B&X=P_T7A^&V1/:?HB"2*TC$]*B&:\0\YBZH2>X:9ZNIK4#"Z#L' 
M>UPLNAT7T)DC/2R,71=@X$OJ6%A_. '+KOJ$Q;;G K8%ZC98?.]'4D3%. :9%1=$EMV\/%)G)N^3][4&^S:L7L$ZO?D#%U>OELK"&[:Z-L&.#
M1FR2&)<7@0I0J7?(P9R I"Y#HLJZ2D55S-,85HEPP,
M!PO33>.2M:%18?HZ7,IPK(!5]=RX-+U*RAK%9*!TW]"E>87#LU1_B4L3#@?7
MM@#GDH&B=V48:K8Z9["+X+/;/G;)7A=!BVZX<'3!0 .M*C$_XSOHO(;75Y]7
MT&;]])?PV-#SB1AYPY ]"/L.:_Q(ZVRNMI6BSK[J^16VJ[3O6ZU!'(B $\A^
M&S8E%AFBB2:9ZMS> -"&M8E6C9P&5&@^ER ]U^ZM4;UE=038JVA]
M@:=6/H)#, L+DBV^.:PN )OMC=D@FL/C I1\$W,6U\W=S$1CM!G,(?!E;2DX
MIOK!7!!^KW*K07'K[QI(2+]#<*92KKZY7<6&M7Y@>C-,!157G.FZ6G TO17:
MS^GI(W3XW?,EG60)5AJ/)^K:Y5B_4ZD69!/DU0SJC#)RT5:K#,M!&U'&7/. ,&*UP%HMF^:V0_02.><#Q"(4Y59Z_8*
M)=4%D5KWT\NAS;-<=)Q&($^H?H/]E/$3E@SD, EG4;09727+4BUJZ]LO7I$/
M9,OD("[5 E>O#[QQN%0EK,DN2G.;!8J)FS11[,-/ESKS:C20JN3>I::^U:O%
MOO[F4A-@G>O+4L;Q?B.541+F8X'_N9G>TZ8>@57%AQ],%1;U)W0,]L-$I<8Z
MI%/]G"LJV+#ET\X-B-*7TH"H?M&V\SJ-%)' \M">[1LY>[(N6FT)KTL
M5$VNO;."IG'3LET5IE'JZZ@HEZ#6;@HFY.7P&M2Z6G+\R1R:)@YK$6DK4QX9
MF0^:F4_6R)Y='N7K%6K>=#J"(>-0R)4O:,ST^G4>2^!J0NK7CUZ,DC4X78 <
MZ>FNYVQJ5.8-P+HE:$K-2OC\B1]!#$/C6]45U,T<7)+I,!.M_/P2 ^7/#:T2
M49_6_ K/8:1K4.1*'9=0-G'6@0 5%.@ Y40M%R%+1CJTA-J(DB<-TV7+8K7X7<:UE5E!.B27,!=D9
M)KKDQBA.7^>AU\MZ#5YN% VPRD)[=1?R=@@J'\8O]>]?JFM/-
M78:Y5C7O;%XL0)>6$S0XI$VZM F!QH9U=X@5,[^A?^C_@*FN_ ]02P,$%   
M  @ .$BM2,.^F[N4%@  * X" !,   !U9RTR,#$V,#,S,5]D968N>&UL[5U;
M<]LXLGX_5><_^'B?&<>Y3E*3V9+M..O:.'+9SLSNTQ1$0A8W%*$%2,>:7W\ 
M4C?+!-F@2!"4^R61)0#L#\3EZPL:O_[]81H=W%,N0A9_.CQ^\?+P@,8^"\+X
M[M/A]QMO<'-Z<7'X]]]^_3_/^T)CRDE"@X/1_.!VDL8!Y6=L2@_^=7+]]< [
M>/G^X_'[J\N#[[>G!Z]>'K_S7K[UCE]YWF^_1F'\XZ/Z9T0$/9"/C$7VYZ?#
M29+,/AX=_?SY\\7#B$O7RY>NC9>G#17'U:Y"L*FP6?GN4_[@J^J3I
MGZ^SLL&(N$Q+Z2180?1?;E5^:3
M).NT2@@'VA+J+V]9S%-?J0Y[??SB002'O_WO_QP'KG+1O(Y(/7UPHL@85QJ(I^E7\N2BOA
M&A,]?S1]2*AK1KR$9A9%\0504"*F!8U#3/JP;G\:$A^Q[+&;4#\+6%;8"K+
M]QA"\;IB%FJN<5FN1,%&',VK12;&;T,^52+
MV+0[O 99H=RL]DP'@CUN'.RCU:IIK,V^T,67+$[DWO4YRD235(;>J0_&?;"A
M@FA@/UW?B@9PP]#C;9+Y$R7.<#SP?9;&21C?
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MU"6LR7DK7Q.B6R;/[1I2?R@ERQ[A^4!26LB/@-;T+%;.)DV]D6C2ERHK9$?%W%DDB1'C>3?KW
MK2EG1\@_:!3],V8_XQM*!(MI<"%$NN:73X2M*-^VT+>FC20Y,>FO1LF_1@1! (ZI5SH$J5,B"JUPZA*F%O0#1O
M'$(#,S"D!**"TL&;;D:0E#\404F,8%^N^O(C/Z"@9Q,$EX3]HHC3*
MS_]-Y$^D]@("Z .H"J N@+H"Z .H"J M8T 5@=,@2GW^WN*#%2\B#(:$O
MKMHVHR][*E+Z&I1>=>8M>3"A]-55>LR']P "4GJD]$CID=(CI4=*CY2^=4H/
MI4.6*/TO7M8N#3PUNGDX2K.K5F81,R<8N
M'PV'Y;99_&L'6:'S/CC=Z (EECIT4<)0@+6<@E-*=\'U]@A2]TQ^3_3?FQ$!=SC
MX^!]GU60-B>- -"7 WN?[I@%T+Z#]IWV[3M6,;8Q5=&JA58M!ZU:S2@X71R,
M\[*PVAW.QVTU8/687.&S;;JU44UT2DWT)S1((SH<#^Y)&*FQ<<[X#8GH.F#\
MFLKEW@^C,,M;FRVU5=:+III%O1GUYEIZWM/UF3!C=@]JJ6V:;R $
M\GWD^P/?3Z=I)(=0[IT[W1P\>3SZ5R:$J2]@EU91.T#M +4#U Y0.T#M +6#
MYZ0=-$ ;+"D-'SRF!-R\YK>.QE#=3-OJ E0"U!505Y#34RX2P=>0C,(H\]"9
MJP6@!E #0 T -0#4 % #0 T -8!GI@$8,(1.S@0$-"%A)#PUM%.R&IDU#@=H
M6K)[2J!4")NL?YW'?#,"C$3A7S3X(L>8TOPT>Z])U1[K GL P0%U!IG^/C!]
M),](GI$\(WFN N0I!^IU$:6;POJ:"\GNJVU"K
M*_28D.T!!.24R"F14R*G1$Z)G+(K3@GE"):8Y..;+7:BDK"F[%[5X0Z91!Z&
M/ QY6"^\^-]C3GUV%RLU_Y8\+!-/::2N*(TT$FDDTDBDD0W32-"J8XE#EER8
ML!.AK-%NAW=#-$$UK=\54?3 I\E#58AJ4=]EJ.$S2G7RC.8LC1.I"C_IH0/TF3"N)IO()!-/,"9.R5.F4BN
M5^N-A@@9U74&&O =F6$V;-2YSK@DB3^1L_#1[Y).TKH= 6C0F4[ *V[PBIL>
M&5/V ((#;P/M0?M@#^J)006O1G'8:H17HZ!!$ V">#4*FD%[8 9M2NT$PG_E
M"OQ&[6I \*^=!M^GE:7BO-LU%,DJ-PEJK#?O*]RF;3EE\DS#_QQ7A0Y[-
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M5D[Y.?B0I"J2
M8(/'E2VXE>7M0U@E"I7C6R-U41'[@GXEL2XZ>?.G#@1;3RGY7K/5;L*B@'*A
MWG$RUPD-K-8IH/+YZ)*6E^DO.O48P6$,_CW-Q5G"@X+@)
MYV*IP!CUYDOG#GJ!,1D;?IP[]V4*MTXN0+'X#K'GJ&V>)C'S#F5
M%B!X<1*A/EBKS<#MVT%A$^RFX3$.3E,3N%7>>>?1(>
M&WL^$1-O'+&?POP ,[RE%L\NFPIA]=CRZC2[N&7J.@&YQV8NJ?4"=LN4"U)N
MXXI:!B?S[T+1Z:'5G4$V):%I<9;*V_!(9@;7,D47T%5%X MHS5,$!74<0'*BBF3[4)U^*;@B18^N
MLDJ/SWWN 00\NHI'5\MD[OKH:CJ;Y2?62*0HR7G$?E[$8\:G>1K$O/BW/G(EOI!
M&QOCW+G)W3J@2?^>G..+S74';MYYYSC4BT-
MDL9ZPAZ%:J8GF@R5<6XA;::+Z@?A.\>^VNR0)C+JV>L)H"V_COO-N8W5%,5C
MHJD_V]#^";:8)=1[XY%E5D,ILY"CS1.K1=H+U!'*:/7VJDZRF;?8XHFVNL+ 
M3K9M=T)Z]^?B#./"4G"9)BF)SM,X$)>/AL_2"0VNX-)%: N#[email protected]"_#JVP
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MA>(!CUO)6<$E32;*XZQ\M=DY
M:/H+H4M*8GJ*$E'7T81;*UW%B5MPO0XA5:SMVG(=BEPY;$I*=B"VLISD@IR%
M0I'0E--O+&:K^-**061:WS[$:RJHY*4JD.=,^H544ZK'SIT]@(#^*?1/EKMMW]%NJ+ G#<:9Q
M#--$JJNQNIX.IK+LUM@>..?09.^^.1M3>SPO8W4I*^JI4=I0A7/._0^7GX',
MC\X-S5H *[1:Y\9J+9 &&I9SOI3:PU9OAW;N1-%N(W?';$&NN<5J6CG<6V^-
M<3PZ(5-AGW5O]=T-;D?.!??6]]V[L<(AX=RRL!/DW;.E65SF=P%JY)IT[F#D
M3M";,''8#I;P-^^;;"AT M:FM4 *$W'LAE4\N>IS^YK/)V$+E370*UKEV*JX
M8?5*!:G)U2=)>#A*LZ0(M^R*\(*[AHO<7LVU[D[WK".\_L$BM8(M [V&\49T
M'P^%_.E,_AG?Y>D!-X0VB!'1@P]J.A1LKFO?Z)OE6GOKB70Z)7R>'R];)9"OE44.VEC;">3,Y+!IWUVF
MZ)^?2YQB0H,OC 7YF%*!#OR^Y/)I<,UN#N]DPI6?VMDNTJ&@U^3GI1PS/"21
M6?=75NP0U!^,_U"9_YE/A1FJZIH]-O[L 02T7Z']"NU7:+]"^Q7:K[JR]IA2
M(.<494.84$[DG/IJB!.J4#@7DV:(LR0.M545^X-'\JN(/+H(C:ZE7%5K8ST2]BD7(2^Q0DO*YT9^)O7($& J O
MWQD$N0N/Y2XLAS2)2B:!4:7.P-R0B'#HR] 4[B!Q/PEY=H_-R7PY0.:G$1%E
M>>Y!=3J$LC'2+RE1<=W!,+Y6'@R^",H6WV,V4FQ(T?B+>)8FR[N+\XNKMX&5
MFG>L/1>[M+'G=F]YR^^P-5S*895Z;!'= PC=#RTTZJ)1UYY1UX -.!<$9&_K
M9B;ZK9-&<-A[+AH8=C=QY^RP70VR$NN%W3Y"#Q)ZD-KW(%G%Z-YBB%XW-U9[
M8*;]:HMHWQQM9J;JGKK7(.:[GGK43,RKSF5S,()8;LH'8GOGSTQ 0XGO'
M(!JCTSF %]^K?T9$4/G-_P-02P,$%     @ .$BM2+)%#'MB(@  GM(! !, 
M  !U9RTR,#$V,#,S,5]L86(N>&ULU3W96G_YK-
M/J ,Y;!$,7AX!O>/51:C_!0O$?C[\>TEF(&#']X??G]S!3[=GX#O#@Z_GQV\
MG1U^-YO]\E.:9+^]I__W  L$",JL8/_\^<5C6:[>[^]_^?+EU=>'/'V%\\7^
M=P<'K_>;T2_JX?2O<=E.Z Y^N\__V [= ?WE-1M[^.[=NWWVUW9HD?0-)$ /
M]_]^=7D7/:(EG"594<(LHK04R?N"_?(21[!D3),N 0A'T'_-FF$S^BO*L->'
MK[X6\8M?_O,_ ."LRW&*;M$XA*E=RG=!VJ:9*"QDF>8=D)9I_H@LR\ 8R^EHA\CVJMV<+&4=\B&,0Y+!X8V*J8
M+2!<[=-/UCY*RZ+YS8Q_Q YKA?Q-_>M?[ZH56<02943*3V#Q>)[B+Q?9'.=+
M]D4X>BC*'$9E0R!;X,\O#&?SY:7T:X/SFG$;K!N%999V]TB)];N;FJ,"5WG$
M/]6$$&HZH&SVZ>[%+UTR0)P448J+*D< ST%$J )S0A9(UG3]M+]>S.Y2C_)F
M.V$>28BM1^Q'F'RX5UL+G>=X:;XC>"2;.=<(@=O;N26MU8))X,'K1OX6OY[B
MJ*+8CC+R62N3\KF#;%O>U$;KRM-A1
M9K>H0 37(Z'K%#VA%*\HE6=?5RACQG>?WR>9.1&E,"4V*RTMP ;,S5,=\W-$\R%)_@K,R3AXHJQQO"
MWS-B->)GE)\2"R)']+D?Y 0<5>4CSI-_$VMP]^/E!H'!
M5]0N(:[EVC[%P^(_/7Z5@@OBD+7":09=>@"E>@\T=(,-PC='V+?7X=\K[X:B([6#W>_O"&U>-%^+V?JGC'Q09F]F2?:$BI+^
MIIB5\"%%Q:ZN-IJNKXFUT+C6LRT)E((W'?PR0TL>4*$!O)O
MI"]\2G L2N$@/J_B^,,&(9R.B8FEVN9(Y%.#XRX$]=T,EX\HGW5(B0FGPIY()%.5T7[=ED=%@J:T>&\7^UXO:(9STFV.,$%.4=97$?3"\F50WF>
MH9:4PG=^%:%X69H$JC&'N8ZH,QH;<\^OR)VV67(TN'Y,D/PF$3:%&89B-@#9
M>8:EC' 3
M-X%15"VKE*6_<_]CKW]7MEUD48Y@@4X1_Z_ O#4!86COZJ#R90#KT&1B$;M=!G7J+\EO^,U0_32R7Y :W*#6,Y&@HEM<'YD^G[1E]'=\P61
MCS5+T^^'Z2,UOQ#DYGO_$"BP%FOQRXE(B!P/.G-LBH@OY\.@J(#/#1F>XP):
M7)=)C_]+>U,!=YX4$4QIRO$Y^QE.L
MP2B_)N3VI_ B6_MOX2HA]H7$/ZH/P-!\5$?D6O!>GG;,IMJ4:NPG,JU**4V 
M2@>('LE$HNW(GW%#;9UAQ$RM-($/2L:.-KPZ,'V;7ASU)(RO/L[VFE]"
M=GDWP/ 2W<.O=9C\[email protected]/JB^G' "]";^-FLK,8@^W^3X*:&M
M_L 5#8.F^Q&H&S?DY1<\:[G=R7-
MWU#(]!6-'YOENPW7>=X:Q4>%CF&<1'JOD+5]J;W#_++;>478-X V%_@K*IAI
MRTR47?^P%7!6NJJHHPW30T6=OO%=/USRPE)_E+VAEAZ\^4=-*/@]<,6L\\DM
M6O%;9P'*1P2>Z@6O^!V&:*]X@T=1A^8"+&&, &O.S";'-9.[@\"*H)M"$Q0#
MG2!L>6*ZC3ZNWVTGXE.BQP>NWKWC1ER[-^!YNW+7=^TS:KX1O,&NV_WC@"G(%:>\>8>X,1GN!K3#8K^2V;H4>
M0@6"JC+%4"Z'0+MO(!KA)T0^R>0;_0!I#]&'0,E)2@S&)ESS'!FC6;:_\2X^8%T,#6)&76WDA@E%.=][['U#
M75JW]:=GG2LB-G!E0PUL7!%(7UU8NCD]P4Q=*5^Q#K.\.]!IOGKKVD>%U'L^
M/-[<==X/U[4D770",& %GZE&#.7>EG 6:[/+=]7L4Q*C+"YN.!N')4DRVKA:
MMA>J\VMW@S:H",E8BC7Y%":6IR0]PX-'QN_\RDY[;0ZL?8;XV1-6FX[@G*(Y
M(D3$1 _RAF?2&+#"#%/](X;L7 ?5J,/G%*BP%QOP+(AI=+G.O54RC<3CQYE&
MNW ]*":*N.TN$M(L&N#JKEDD8]7OVWM"3L?UW)_S9!O=1'PG#5F^LL]^IYVCX]#UU+^'+CU/9^P)M5K!WJ(5
MSFETEV;)]&8VJPPW\$ -@77>JI _?MH3[3M&>%'(/[9H"4!%!0&O; "N;@B:('+Y,,Q#A-
M85[0L XH*#'?ANG5H+$/> 1SW2LL=AI."!D+G#\+U57O*&-EM0'-DZIB.$&#
M-)"BZFCH$
M\K#KY1ABCX]\RGN"HT?W]?UY1/8D!>,M:9(B"Y8IN<$P+.-"$+UV!XD=H>H(
M%0P>I]FV@'I6;5O81^BVT>LPJ3R$SV1JRDJZ#!VX'DH+MA$&+YYCYBG6)E106X3-SF>HX+6.\#T'"G>*B23QMTN!, ]
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MK*>54#BP.L?7BX2DV#T4)'-%1EH
MW).I1%E4A 8;\,V_)X&'9(J+[!0]E$=9?-4VAN#?A4[6>1:?H+R$27:?0VIC
M\VJMGM=(!_P0+M&-\&*X(,N]K=W235^.H)2SV/Z:=L")!VOJP4LZHEX J%< 
M^!*^[?:M#^[6=BXLV+<$^#W;5_"?.*=Y0\7UO%[2]D).\9(L0G!8M><;GCYE
M/*Z/$R.$I8"QYK3M<=H]0Y\Y06'.A?Z^X-',#M0@N?/4PPTN$I9$,/S,D,[4
ML6V3!U"X%[email protected](+?1V6E5D[.94ZT,=;<[8[=>JCQ[>&,@W7
M_EMW1_04J7EK<%LWX8(_
M;WHQZ@YD+R]9&NIG1B@(??NRM;O8T99YS@AMGBM<$R=::\ 1(/M9BK?N50.0G?>N)]N&1[.PGV5I+J30/C4=T7I?-Z<9#C
MH)9DZN7J=+48/E>KT<<^SZ9"C%4SB^C'[1L/S7*YA-Y/&
M3%.#0([!^;>?D]!V".(7)=[KI';L0$9/H*?UU+< C^"K[WS<*$>P0.2VR?Y[
MD34UE*WMK9^\-3I.(
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ML=T0Q1C<9YIPS&"5X[B* CGG=5C=US]0E7]^18^^2@R+QYLGI$TI #8TO(^B.R.
MV!QLC^.!E.K? .I?X/N2^?"?CJ#1QL?CFBT$Y%B$11%0]K&HBP<-SKWZ8N'H8E&HC
M52'?DDFHC1Z[<;S:T 3J_.XQ0;6A2*5%M>&,+V/41D5(HP9PWRUM2BI#5Z*-
M+FQ34QEW$VQ.)!WZQ9^N8(ERA.8ZCFWI!/'^K:$"%R+)D$,
ME@WFL(XM.9/[_%J*G/.>QD_+9)N\"HGO2C+:/'6_#ZK[GM2\R'F=!!,V,U3&
M7*S)L4!Y4XV-,-!>='#LV.RI+DQ?]ES(SJ##S.Q+GA)S*%1+__:9@8'/FV#D
MZ$;Z+41_/?!#O@8QQ,K>-O,"_O@N@*0^P/+YAG"T:6"[4OA@*<\S+GZ4P'=?
M^L@)V ,K2@*K?$0-$6%B*.H\Q\:,#%WK6"<,TH?C4?(TD#NN,]5:Y>,NBG %
MD+NTV*F#'+7&,>60#6*0*Z[(6UGD@&0-5D?*6!FL)0AUXH2M_N;=TA8Z+E3LJ"?\]HG]&>KNLE_-KT>2 :F+Z^"YI6%4T24692P8#7Y.44E[VEWM,1YF?R;_5YX610%
M]BR#-^^#8(4,U^KB$A7%^XVW0.(.N:&Z)MC=0>QZ6[S[QR*$XN*<<.T.IH@]
M"EG2#_WS]7S]/.3ZXR_VEYG!,?>?Z>'SX$]C!/'$9!HQII>OY?J9TJ(E)91S
MS7"#L#6N3\3U*PX7J$RQ[?#U$$!0H<&H\MKJFHS?8%@-N;+W0"9;G&]WMB!R
MHL[-0&E2YSB_V\B$&>X@J3QO;!*4"+[K8W6EK]R]K<2@E\$Y3'+ VNF'3=N2
MBDM?EI8:YSP_Z4,4D>!L=/]D^FP/ >'
M/WI".5R@CQ7M%7 ]9^W[KMY%"A)6?VM$I4I8Q.3 [PYTN*>
MU)LB2LSN2U">V-L@QU7"8E<%T9872UH/RJ+(/'%?(&A*323D> ^_:O2Q[YMD.X3(@ HPT;.8>V^G]ZQ*5:?J5 Y)<'_8.S;3V*V^H
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MRXO[B[,[L-N"''\'9_WZZN/]'F#(552'#IMSU
MG) %4U3450---06C3-.K-J&Y/CCTP0=:G1WF^B)B'5;D1ZC\/&*[Y!6*
M.[*KF:&G"F!TCIX,D<\LO9H6T"%F>FEZRCO3FZBGQV[O#PVMS6J!A/:.,7\&
M: W+AQXSO]6.)-7PH9V ?=7Z]QDK<21 <1TG99T[]A%G;?Q!$BK2GC^F"$\%
MCY_"/"Y; 4ORM%B^7::GS\= I7O#K=:WAXPMS?/47)WBHM]F5M5I5J(RAF#C
MS+YD37O8@L&!7O#];/$KO2=XN4QX()-)V5@HS#&5[ +)K4>^@
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M,+_AN[@H=5"SV2_'9'64R[4-DS4+LM@;1M 19:1B+B+/:J:+3_4YL
M%BI,,K<1!X#[,AAYO1RC80]P*D"'C&"-$#6W )OQU;>CL&"N)4F!@&B8L4MP
M$YRO#^8V7I-/YWC:C;W?$47-J]E#5CD(A0&KWU'^7UQUPBT\9
M?BA0SEZ;O,A65=D4IO$,UN/G!L;S"?5OG>(E3$2YRM[PFO9X S)R+,2?*W]SC8A@8ZQ=ND==^5%TGXT)RQIZ 3J/NBHCX 6VYY#&TNZ>EP\XW3ILPK\;A$DWX#CO
M0\N1 8[->["SGV=8R@C/63W"%S'KA@XHIM$H4=J/WFS3O" U+.[K(8HP-P]=
M+BL]>#K .K\22).R([S(*"U$^QVC#,T38:*99+2AA F@^OJ4"]";?+:MK<3@
M$]W%S5YD4%N(HU,CDQ2LR3354U$MF*0?O&[D?/%K_84_RK(*IK=H14[>%:+/
M=FX+N<)070D? .FARQKK9\ Q XX:?.;()<$-EZN(<5113TM/.57PE7$!.MPS8)L5W%2GB,DD^O>8>8RO0'.FSQ3K("@'2O+(ZD?*<=L
M%7.RBL RW"\26)53XV7WE%8!)@\592-!LOV _,Z^2<8;2[, KG,K1$: F71;
M6XU)$_L.;BKB>J:4_26,.ZFQWFJ8UCXHT-6D!K@&D),.WR1GW]M$M&W<9^ DLTUX%K
M0L":DCW0KOL#JX"FY(1Y+4?K2.$Q#/;^;@[M'4[;333ZC\9XSY:K%#^CG.;2
MYJQI*LR?NX..EK323Z!_[  U?W-G!')?.FLY"F#\,-=><28DM.-^NJB&\@M;E4.L#9
M@^Z@;8@&%7[J/?I>"PC82\[BYBDV!3'>D6 =:86!D,T\>=T^M:/ CN]>:X3>
M:T_;AL+9'.VX[>UO@6MASR:2J-,I2]'-T.F9:CLUIX,B
M>$Y.AQ:KR3BCUFC66X6YI(*6T&H)E4KJC9"+D[HY7L$R>DRRQ<;?$=DGTUNC
M D W-\8!Q!.Y+0Y0Z."F:)4?CFZ)#8T;@_9 32;]U-=#4?'?@#VS#FZ@WW9E
M%L5>_=JHO'?>O]FUJ7Y.>,-[GU:$S/K]1)S5??TZ68=728:)(?)\D1$10@4M
M2MB$PA\P:X8,$ZG(?OX13B(.()['6(]GB"U(&A,:.:Y?E*$>A#:MXZSSP5P+CY#\<(
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M-_\/4$L#!!0    ( #A(K4A!7A+#*Q@  &=% @ 3    =6W[] 4C)DF6";) B0<+]DHN(2_=' .ROT6C\\H_[1;1W1[D(6?QY
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MHXE(./&354<1F=!(M6%0)Q1(*/V(BY?1&8G(D._FN4P1>8^!J>&_L*3)6X_8\)),P
M"I.0B@(Q-0H9U.Q>K6N?QH2'[%LL;JD?3D,:R&\ "6.-,I7E+:BPFK5R9:)G
M\I]")[NVH$6A5X".[L-*N8O*6A3]ADPB6B7SDT)EPFY^8T;/DI!N/_DR_6\H66)@UO"
MU:?+GX=1L*H]Y6QA^O5@,&!DM\,&I5S'(A3T0]HY, I59<9+*QB7PX'@4CU(
M-.MU>R,DD0R*GMN!X[FRK)9QY,K\@9BUK(&UM<;IEX-"LK,KXO;1DT5DXW,:
MB_".2@XD__\(&8B[E3?1/GV#](\,;CD2CS>A.LN04N)6T05HM8%S.4?4L$E)
MD;LA=T/NAMP-N1MRM]X.$N1NR-V@W,W,].V,N+WU./4C(H2FWJV<
M[MS;[-.(RIDVVCZYJR<1TCUD1[UD1U=;@UEGH6O+(:%#0H>$;A#F!A(Z)'1(
MZ)#0(:'K%Z&KL*TZ8W!OO D1H70.U)8C:0CO6+CE78NIW1L4,O
M)HD46E&922KD2Q6/;Q3$Q.+ PI32\IS9C/2!S^E7&_!A/"X;36B=9^CJ*?^H>!XMV'5R)_^'$D9 B7':42V]^&TS^L:7E"A
MCE.NIL:I')(D^C"YACIWWYIN:Z$O)']E,BV^;AMD;YDZ\BQ[)63Z$RN&/?_I \%
MLI66ZTA(MEBP^#J1WY'KN?P2BG&:J-Q?P?-X +-*'8F?KSM7])9Q]7%4']+"
MF00IWHW(IV%$^;&<(#/&]8.BL%0W E[16:BLFSCY2A9%4ZJL6#-HG_&[$=\38E@,0W.A$@IUPI;4;YMH6\X4?/W^F$Q85&!
MD(7/380J<.:O%F=IZ^88G#TWO=9N?$AI]%^B_Q+]EX-@U\ )C9Y+]%RBYW(X
MGDM+2!0Z+6'6JG.CH@*+4L()!N/-T,$H,6C!(+P=.@@PQQT8CW=#QZ.2?8.A
M>.\&%!"7"1B3#VY@4NI6 (/QT0TP0&X+,"@_N0$*W$,*1N;3T)'1>^+A!MC@
MK5' 5@D@S=)@5N3<$0&;Y^6;'QW%[email protected]+$!C)0,H
M"K^P9OOA]R7=8MP]QMWW,N[^;#UBS^(3.E%.X0O"O]-$N;B^_#>55M4U]5.>
MY2R7#X\I3T@8+UG\2 B:&%PYTW9WN ^%^U EDC(U9&_(O0DIJZZ"I Q)&9*R09@,2,J0E"$I0U*&I*QOI QJ
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M:I&1Y=5D>8_'29;Y:0W9'*PZLC9D;>L
MS<3XZXR=??1D$=GX7&T=WM'U.5]CF@9JJ7V^9B#&[HD;J', @S-0 JEC5R'%58WTSXEA,JP>SY8W3. #$+%1R98
MGPG*Q2$X#\DDC+)M='/2!VH ^1WR.^1WR.]:XG> #P62.R1W2.Z0W"&Y:X/<
M&1B!E@[9!30A822\1$J5DLB(RH%:ZOK87:D8C5(3%Z6+.,E[NWG:V=.,4_!Z
MW1M1ZWN,-D.&213^18/?Y *OO \:TPI2U8LMY@=R@9(B6W.!K0WL6V>\;"&)
M0!*!) ))1&,24I"@D6QN2'1F&3^]#JZ1:0QKJNL;[M X1JL2
MK6Z
M%11(V*2Y>AYCF%*JLR]RI+ 'RK42C18LC1,IS+\IX:,TF3.NYAU(S28=[$QQ
M5YF7!N]C)I*KQ^518Z>"ZMKGV?D]6[S922-21J$B7RW.4)S*;Q/(G#FHV:MM[I]LPO18)LXNW$,
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MVB*2PQBF0ED5*XJH"T_RZ7BCTJ95:E%>WIH*&W>V@%30E[?J SRAC!>-)^%?V^R5GPN,U?$;UQ_:Q&HCH5H7"+F4B+UEUHA[R304JA1%=&$AN!*,K%:6[%_\TO$]2%96T8WB%'N$;JHB+="WI.8MV)DLU'%@1;3RKY7K/U;LZB@'*AWG'RH!.Z
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MEI"HVR!;^(I;%FGCRO<99M09.KE=,?#@:F]@][email protected](ZW*_9<+8P,
M K':,^XL+,6UP#+;H'+% JP%53OQR>V9C(,?@@7;BJY8E;6  L18.&5;UINE
MA7'G8%Q^*8*#I*+]CDHI!8.D?EE(0-9
MI:L#'>$@#>$2D'J#R3#2' Z9B^8Y^&R'*^08YFR"AFFXXF4"Z%N=V^8BGR1)I)B&L'1
MPS>A2-E8&DQ$63PC/Y$<)!M!%:?(6^S*P6/.-I/OMJ^H5
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MPWAJ\D;KMF-%Y;M0R)E>_UD\97Q!((E9S&H[G;="/WDP7X4.!*TB]20VV70_NH41^RE'.*8S%6G7\<'WCH"N
MY7AW)0JS*Y#AW@E7D(6MNW4W*5M836W.]1HPE(((B*YP;+7<-8)E80 M3%&7
MH*NUZ]Y"P+J#F!;O\+<8S][]0;:VED)-[%6+V1&U@1W4"R)DG,J
MJ4(S^'8;%]#>,:@^&M-- XL<,ZH;P+')W.H'";CB0ML1D,W"#QPSNEL:G* @
M':<.A^X&R-V&)#IUP'0W #C9Y? R^_KCQQ!]2*HYFE_B02ZE
MM8XQMC?1^VA?UHIR<67?RU3YIY10?RRQBQ/V,4OD,N"150P],\ALG"!_\T*6R8F6=-,]SJ6NDPNVVY"%UF
MME4+Q7AZ1>]HK,]56E3&0D92*49VPUX>&JWC^]O%;&:]624>OZ3\>BZG[1$1
MH2]E.PFC=..U;VD K&4KGZA:"E0X4E%,QY%:3.C&UMU%&#,5K'06R\\$%=I*;NA?V,^&U)0>09,OF&%_'-V\MV!6C'5S/HDH5GRAM.8LB
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M#EY"Y5:76]_1)H"5[E:Y$D-O(8+OL%; *.2:@7EI0IW
ME0M7DO!PDF89?&[89;9\0+9_=]=Z?^!9AVW^'XO4.K:*WAS'&W'"/!3RT8G\
M;SS+T\GDUI]^0+?>W_ AK%@2VNK.>A3&#G7J#CVK(P_C"RP+/9[FHT?E+GH^
MIN!WGIFT@N$4]L,IANDCJSO@,-) AP)&&F"D 48: -,CXV57K3%&5\;2KL$!
MX+YCXNG*8![0FZC_#LPWBBSM>PSC1>@\">[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M)+ZNM#7Q-^YC!BF@+V]-!6G!3*4%(VQ,[ZM118;+KFE%>R.=C11XP^8O01[]9'#+!0
MT3N\A8+!!]054& J,Q,RZXH#L XT)03;%5APDZ4/FRP]]P[#YXX=8]T5G/N\
MF=7?FV\@SJ\6<^/T#A=3IZQ3*6N,QDR%AZC%W:N> P/T +J2E,8(FW(W=7M9
M9WH[9LP\46" /C@T9JIV!B ;P\LGZH\)$53^\O]02P$"% ,4    "  X2*U(
MAOI>NHPM  !EU0$ #P              @ $     =6&UL
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M        @ $&5@  =6&UL4$L%!@     &  8 ?@$  /60      $!
 
end

Categories

SEC Filings

Next Articles

United-Guardian (UG) Misses Q1 EPS by 21cMay 13, 2016 9:05 AM

StreetInsider

Log in to your account:

Form 10-Q UNITED GUARDIAN INC For: Mar 31

Categories

Next Articles